###begin article-title 0
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
The Polybasic Region of Rac1 Modulates Bacterial Uptake Independently of Self-association and Membrane Targeting*
###end article-title 0
###begin p 1
These authors contributed equally to this work.
###end p 1
###begin p 2
Present address: Dept. of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461.
###end p 2
###begin p 3
###xml 303 325 303 325 <email xmlns:xlink="http://www.w3.org/1999/xlink">Ralph.Isberg@tufts.edu</email>
 An Investigator of the Howard Hughes Medical Institute. To whom correspondence should be addressed: Dept. of Molecular Biology and Microbiology and Howard Hughes Medical Institute, Tufts University School of Medicine, 136 Harrison Ave., Boston, MA 02111. Tel.: 617-636-1392; Fax: 617-636-0337; E-mail: Ralph.Isberg@tufts.edu.
###end p 3
###begin p 4
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 4
###begin p 5
 applies to Author Choice Articles
###end p 5
###begin p 6
###xml 408 435 408 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia pseudotuberculosis</italic>
###xml 858 866 858 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia</italic>
###xml 1352 1353 1352 1353 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 408 435 <span type="species:ncbi:633">Yersinia pseudotuberculosis</span>
The COOH-terminal polybasic region (PBR) of Rac1, a Rho family GTPase member, is required for Rac1 self-association, membrane localization, nuclear translocation, and interaction with downstream effectors. We previously demonstrated that phosphatidylinositol-4-phosphate 5-kinase, one of the effectors that requires the polybasic region for interaction, is necessary for efficient invasin-promoted uptake of Yersinia pseudotuberculosis by nonphagocytic cells. Here we further examined the role of this region in invasin-promoted uptake. Using fluorescence resonance energy transfer experiments (FRET), we determined that engagement of integrin receptors by invasin caused elevated levels of Rac1 self-association at the site of bacterial adhesion in a PBR-dependent fashion. Self-association could be disrupted using several strategies: translocation of the Yersinia YopT prenylcysteine protease into host cells, inactivation of the Rac1 isoprenylation signal that is required for membrane localization, and elimination of the PBR. Disruption in each case impaired invasin-promoted uptake. To determine if there is a role for the PBR in Rac1 effector signaling that was independent of its role in membrane localization or multimerization, we examined the effect of the PBR in the context of a Rac1 derivative that was targeted to the membrane via an NH2-terminal lipid tail. The membrane-targeted Rac1 derivative restored significant invasin-promoted bacterial uptake in a PBR-dependent manner and yet displayed no detectable self-association. This study indicates that, in addition to its role in promoting membrane localization, the PBR exerts a positive effect on Rac1-controlled bacterial uptake that is independent of Rac1 self-association, most likely due to signaling to downstream effectors.
###end p 6
###begin p 7
###xml 49 85 49 85 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">National Institutes of Health, NIAID</grant-sponsor>
###xml 93 103 93 103 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">R37AI23538</grant-num>
###xml 108 135 108 135 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">NIDDK Program Project Award</grant-sponsor>
###xml 142 152 142 152 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">P30DK34928</grant-num>
###xml 190 221 190 221 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Howard Hughes Medical Institute</grant-sponsor>
###xml 364 377 364 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant R37AI23538 and NIDDK Program Project Award Grant P30DK34928. This work was also supported by the Howard Hughes Medical Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 7
###begin p 8
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 8
###begin p 9
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 219 246 219 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia pseudotuberculosis</italic>
###xml 354 355 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 356 357 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 577 578 577 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 710 711 710 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 713 714 713 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 810 811 810 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 219 246 <span type="species:ncbi:633">Yersinia pseudotuberculosis</span>
Uptake of pathogenic bacteria by normally nonphagocytic cells is uniformly regulated by members of the Rho GTPase family, including Cdc42, Rac1, and RhoA (1). In the case of the Gram-negative enteropathogenic bacterium Yersinia pseudotuberculosis, Rac1 is required for uptake, whereas Cdc42 and RhoA play either no role or a negative role, respectively (2-4). Rac1 can facilitate bacterial uptake by remodeling the actin cytoskeleton through one of three mechanisms: 1) inducing actin filament nucleation and branching by activating the Arp2/3 complex via WAVE family members (5); 2) increasing phosphoinositol 4,5-bisphosphate concentrations in the plasma membrane, resulting in uncapping of actin filaments (6, 7); or 3) inhibiting actin depolymerization by activating LIM kinases, which deactivate cofilin (8).
###end p 9
###begin p 10
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 1014 1016 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 1018 1020 1015 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
Activation of Rac1 requires GTP loading by guanine nucleotide exchange factors (RacGEFs), which show specificity for subclasses of Rho family members (9). Exchange takes place simultaneously with release of Rac1 from RhoGDI proteins, which maintain Rho family GTPases in an inactive state in the cell cytoplasm (10). Release allows insertion of Rac1 in a target membrane via a prenyl group linked to the carboxyl terminus of the protein (11). After exchange and insertion into the membrane, active Rac1 is able to bind downstream effectors, many of which modulate the actin dynamics associated with bacterial uptake (12). The activation observed is often a response to engagement of cell surface receptors, resulting in interaction with downstream effectors (13, 14). One example of a group of host cell surface molecules that activate Rac1 in response to substrate engagement is the beta1 integrin receptor family, the members of which bind envelope proteins encoded by a wide range of pathogenic microorganisms (15, 16).
###end p 10
###begin p 11
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis</italic>
###xml 157 159 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 269 271 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 472 474 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 661 663 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 665 667 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 0 21 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
Y. pseudotuberculosis undergoes high efficiency bacterial uptake after engagement of beta1 integrin receptors by the bacterial cell surface protein invasin (17). Invasin binds integrins with a much higher affinity than natural ligands, such as fibronectin and laminin (18). Invasin is also able to form multimers, which is predicted to allow receptor clustering, thought to be a prerequisite for triggering intracellular signaling processes required for bacterial uptake (19). The combined activities of high affinity binding and multimerization by invasin are critical for high efficiency invasin-mediated bacterial uptake that is regulated by activated Rac1 (19, 20).
###end p 11
###begin p 12
###xml 33 54 30 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis</italic>
###xml 209 210 206 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn5">4</xref>
###xml 221 222 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 671 673 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 33 54 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
Engagement of beta1 integrins by Y. pseudotuberculosis triggers efficient recruitment of Rac1 to nascent phagosomal membranes, resulting in localized accumulation of the activated GTPase, as determined by FRET4 analysis (2). Although the most attractive model for Rac1 function at the phagocytic cup is that localized activation of Rac1 occurs at sites of receptor engagement, it is possible that active Rac1 is simply delivered to these sites by release of the GTP-loaded form from their soluble RhoGDI-bound complexes in the host cell cytoplasm. The latter possibility was suggested from a study in which fibronectin-coated beads were used to challenge cultured cells (14). This raises the possibility that Rac1-GTP can be sequestered by cytosolic RhoGDI and then directly delivered to the site of receptor clustering without a membrane-dependent activation step.
###end p 12
###begin p 13
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
An additional mechanism for regulating the activity of Rac1 has been proposed. Gel filtration studies and co-immunoprecipitation experiments indicated that the polybasic region (PBR) at the COOH terminus of Rac1 mediates self-association of Rac1 (21). This self-association is independent of the nucleotide status of Rac1. It has been suggested that PBR-mediated self-association potentiates Rac1-GTP to activate effectors, based on the observation that Rac1 derivatives lacking the PBR are defective for activation of the serine/threonine kinase PAK1 (21). If local engagement of beta1 integrin receptors indeed triggers a localized RhoGDI release from Rac1, there should also be an induction of Rac1 self-association at the sites of integrin engagement.
###end p 13
###begin p 14
###xml 92 113 92 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis</italic>
###xml 92 113 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
In this report, we investigate the role of the PBR in supporting invasin-mediated uptake of Y. pseudotuberculosis and identify sequence elements that are important for Rac1 self-association. Using derivatives that allow membrane localization of Rac1 without the presence of the PBR, we provide evidence that the role of this sequence in the uptake process appears to be independent of its role in self-association, presumably because the PBR is necessary to interact with downstream effectors or guanine nucleotide exchange factors.
###end p 14
###begin title 15
MATERIALS AND METHODS
###end title 15
###begin p 16
###xml 0 50 0 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cell Culture, Transfection, and Plasmid Constructs</italic>
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 205 206 205 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 378 381 378 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">183</sup>
###xml 392 395 390 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">183</sup>
###xml 434 436 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 438 440 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 691 692 689 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 1017 1018 1015 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 1163 1165 1161 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
Cell Culture, Transfection, and Plasmid Constructs-Culture and transfection of COS1 cells were performed as previously described (2). Mammalian expression plasmids pmCFP-Rac1 and pmYFP-Rac1 encoding the NH2-terminal fusion of monomeric cyan fluorescence protein (CFP) or yellow fluorescence protein (YFP) to Rac1 as well as Rac1 derivatives having the G12V, R66A, C189S, or 6Q (183KKRKRK --> 183QQQQQQ) mutations have been described (22, 23). The K186E mutation in Rac1 was generated using the Stratagene (La Jolla, CA) QuikChange site-directed mutagenesis kit. pLyn-mCFP consists of a 10-amino acid myristoylation/palmitoylation sequence of Lyn kinase fused to the 5'-end of the mCFP gene (6). pLyn-mYFP was generated by replacing mCFP with mYFP. Rac1(C189S) or Rac1(6Q/C189S) devoid of the geranylgeranylation signal were inserted in frame into the COOH terminus of pLyn-mCFP to generate pLyn-mCFP-Rac1(C189S) or pLyn-mCFP-Rac1(6Q/C189S). mCFP-GerGer and mYFP-GerGer containing fluorescence protein fused to the CAAX geranylgeranylation signals, without the upstream polybasic region, were kindly provided by Dr. R. Tsien (University of California, San Diego) (24).
###end p 16
###begin p 17
###xml 478 485 478 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
Plasmids encoding HA-mYFP, Lyn-HA-mYFP, Myc-mCFP, and Lyn-Myc-mCFP fusions were constructed by replacing the enhanced green fluorescent protein gene in pEGFP-C1 (Clontech) with each tag-encoded gene indicated. Various Rac1 alleles (WT, R66A, 6Q, C189S, and 6Q/C189S) were then cloned into all four plasmids. All plasmids were verified by sequencing. Oligonucleotide sequences are available upon request. Rac1 derivatives used in this study and their properties are described in Table 1.
###end p 17
###begin p 18
###xml 0 7 0 7 <label xmlns:xlink="http://www.w3.org/1999/xlink">TABLE 1</label>
###xml 7 42 7 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rac1 derivatives used in this study</bold>
###xml 7 42 7 42 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="19"><bold>Rac1 derivatives used in this study</bold></p>
###xml 7 42 7 42 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="19"><bold>Rac1 derivatives used in this study</bold></p></caption>
###xml 42 55 42 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Constructions</bold>
###xml 42 55 42 55 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"><bold>Constructions</bold></th>
###xml 55 65 55 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Properties</bold>
###xml 55 65 55 65 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><bold>Properties</bold></th>
###xml 65 87 65 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Predicted localization</bold>
###xml 65 87 65 87 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><bold>Predicted localization</bold></th>
###xml 42 87 42 87 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th colspan="1" rowspan="1" align="left" valign="bottom"><bold>Constructions</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Properties</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Predicted localization</bold></th></tr>
###xml 42 87 42 87 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th colspan="1" rowspan="1" align="left" valign="bottom"><bold>Constructions</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Properties</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Predicted localization</bold></th></tr></thead>
###xml 87 103 87 103 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (WT) </td>
###xml 103 114 103 114 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td>
###xml 114 138 114 138 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td>
###xml 87 138 87 138 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (WT) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr>
###xml 138 154 138 154 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-Rac1 (WT) </td>
###xml 154 165 154 165 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td>
###xml 165 189 165 189 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td>
###xml 138 189 138 189 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-Rac1 (WT) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr>
###xml 189 205 189 205 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-Rac1 (6Q) </td>
###xml 205 223 205 223 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Missing Rac1 PBR </td>
###xml 223 234 223 234 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm </td>
###xml 189 234 189 234 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-Rac1 (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Missing Rac1 PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm </td></tr>
###xml 234 252 234 252 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) </td>
###xml 252 278 252 278 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective </td>
###xml 278 302 278 302 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td>
###xml 234 302 234 302 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr>
###xml 302 320 302 320 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (R66A) </td>
###xml 320 350 320 350 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Defective for RhoGDI binding </td>
###xml 350 374 350 374 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Predominantly membrane </td>
###xml 302 374 302 374 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (R66A) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Defective for RhoGDI binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Predominantly membrane </td></tr>
###xml 374 393 374 393 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (C189S) </td>
###xml 393 419 393 419 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Missing prenylation site </td>
###xml 419 442 419 442 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Nucleus and cytoplasm </td>
###xml 374 442 374 442 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Nucleus and cytoplasm </td></tr>
###xml 442 461 442 461 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-Rac1 (K186E) </td>
###xml 461 490 461 490 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Defective for PIP5K binding </td>
###xml 490 514 490 514 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane and cytoplasm </td>
###xml 442 514 442 514 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-Rac1 (K186E) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Defective for PIP5K binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane and cytoplasm </td></tr>
###xml 514 525 514 525 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-CAAX </td>
###xml 525 542 525 542 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Prenylated mCFP </td>
###xml 542 552 542 552 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 514 552 514 552 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-CAAX </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Prenylated mCFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 552 563 552 563 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-CAAX </td>
###xml 563 580 563 580 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Prenylated mYFP </td>
###xml 580 590 580 590 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 552 590 552 590 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-CAAX </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Prenylated mYFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 590 613 590 613 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) (6Q) </td>
###xml 613 652 613 652 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective; missing PBR </td>
###xml 652 663 652 663 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm </td>
###xml 590 663 590 663 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective; missing PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm </td></tr>
###xml 663 689 663 689 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) (C189S) </td>
###xml 689 741 689 741 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis defective; missing prenylation site </td>
###xml 741 764 741 764 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and nucleus </td>
###xml 663 764 663 764 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis defective; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and nucleus </td></tr>
###xml 764 790 764 790 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) (K186E) </td>
###xml 790 845 790 845 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective; defective for PIP5K binding </td>
###xml 845 869 845 869 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane and cytoplasm </td>
###xml 764 869 764 869 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) (K186E) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective; defective for PIP5K binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane and cytoplasm </td></tr>
###xml 869 897 869 897 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (6Q) (C189S) </td>
###xml 897 946 897 946 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td>
###xml 946 956 946 956 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 869 956 869 956 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 956 979 956 979 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (C189S) </td>
###xml 979 1020 979 1020 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td>
###xml 1020 1030 1020 1030 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 956 1030 956 1030 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 1030 1053 1030 1053 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (C189S) </td>
###xml 1053 1094 1053 1094 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td>
###xml 1094 1104 1094 1104 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 1030 1104 1030 1104 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 1104 1134 1104 1134 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (G12V) (K186E) </td>
###xml 1134 1204 1134 1204 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; defective for PIP5K binding </td>
###xml 1204 1214 1204 1214 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 1104 1214 1104 1214 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (G12V) (K186E) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; defective for PIP5K binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 1214 1244 1214 1244 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (G12V) (K186E) </td>
###xml 1244 1314 1244 1314 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; defective for PIP5K binding </td>
###xml 1314 1324 1314 1324 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 1214 1324 1214 1324 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (G12V) (K186E) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; defective for PIP5K binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 1324 1354 1324 1354 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (G12V) (C189S) </td>
###xml 1354 1421 1354 1421 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; missing prenylation site </td>
###xml 1421 1431 1421 1431 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 1324 1431 1324 1431 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (G12V) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 1431 1461 1431 1461 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (G12V) (C189S) </td>
###xml 1461 1528 1461 1528 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis defective; missing prenylation site </td>
###xml 1528 1538 1528 1538 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 1431 1538 1431 1538 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (G12V) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis defective; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 1538 1566 1538 1566 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (6Q) (C189S) </td>
###xml 1566 1615 1566 1615 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td>
###xml 1615 1625 1615 1625 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 1538 1625 1538 1625 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 1625 1653 1625 1653 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (6Q) (C189S) </td>
###xml 1653 1702 1653 1702 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td>
###xml 1702 1712 1702 1712 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 1625 1712 1625 1712 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 1712 1747 1712 1747 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (G12V) (6Q) (C189S) </td>
###xml 1747 1822 1747 1822 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; missing PBR and prenylation site </td>
###xml 1822 1832 1822 1832 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 1712 1832 1712 1832 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (G12V) (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 1832 1867 1832 1867 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (G12V) (6Q) (C189S) </td>
###xml 1867 1942 1867 1942 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; missing PBR and prenylation site </td>
###xml 1942 1952 1942 1952 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 1832 1952 1832 1952 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (G12V) (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 1952 1972 1952 1972 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (WT) </td>
###xml 1972 1983 1972 1983 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td>
###xml 1983 2007 1983 2007 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td>
###xml 1952 2007 1952 2007 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (WT) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr>
###xml 2007 2026 2007 2026 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> HA-mYFP-Rac1 (WT) </td>
###xml 2026 2037 2026 2037 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td>
###xml 2037 2061 2037 2061 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td>
###xml 2007 2061 2007 2061 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> HA-mYFP-Rac1 (WT) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr>
###xml 2061 2081 2061 2081 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (6Q) </td>
###xml 2081 2094 2081 2094 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Missing PBR </td>
###xml 2094 2105 2094 2105 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm </td>
###xml 2061 2105 2061 2105 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Missing PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm </td></tr>
###xml 2105 2128 2105 2128 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (C189S) </td>
###xml 2128 2180 2128 2180 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective; missing prenylation site </td>
###xml 2180 2203 2180 2203 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and nucleus </td>
###xml 2105 2203 2105 2203 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and nucleus </td></tr>
###xml 2203 2225 2203 2225 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (R66A) </td>
###xml 2225 2255 2225 2255 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Defective for RhoGDI binding </td>
###xml 2255 2279 2255 2279 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Predominantly membrane </td>
###xml 2203 2279 2203 2279 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (R66A) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Defective for RhoGDI binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Predominantly membrane </td></tr>
###xml 2279 2303 2279 2303 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP-Rac1 (6Q) </td>
###xml 2303 2331 2303 2331 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR </td>
###xml 2331 2341 2331 2341 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 2279 2341 2279 2341 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP-Rac1 (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 2341 2364 2341 2364 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP-Rac1 (6Q) </td>
###xml 2364 2392 2364 2392 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR </td>
###xml 2392 2402 2392 2402 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 2341 2402 2341 2402 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP-Rac1 (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 2402 2428 2402 2428 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP-Rac1 (C189S) </td>
###xml 2428 2469 2428 2469 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td>
###xml 2469 2479 2469 2479 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 2402 2479 2402 2479 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 2479 2506 2479 2506 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP-Rac1 (C189S) </td>
###xml 2506 2547 2506 2547 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td>
###xml 2547 2557 2547 2557 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 2479 2557 2479 2557 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 2557 2588 2557 2588 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP-Rac1 (6Q) (C189S) </td>
###xml 2588 2642 2588 2642 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR; missing prenylation site </td>
###xml 2642 2652 2642 2652 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 2557 2652 2557 2652 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 2652 2684 2652 2684 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP-Rac1 (6Q) (C189S) </td>
###xml 2684 2733 2684 2733 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td>
###xml 2733 2743 2733 2743 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 2652 2743 2652 2743 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 2743 2757 2743 2757 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP </td>
###xml 2757 2777 2757 2777 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated mCFP </td>
###xml 2777 2787 2777 2787 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 2743 2787 2743 2787 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated mCFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 2787 2800 2787 2800 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP </td>
###xml 2800 2820 2800 2820 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated mYFP </td>
###xml 2820 2830 2820 2830 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td>
###xml 2787 2830 2787 2830 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated mYFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr>
###xml 87 2830 87 2830 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (WT) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-Rac1 (WT) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-Rac1 (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Missing Rac1 PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (R66A) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Defective for RhoGDI binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Predominantly membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Nucleus and cytoplasm </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-Rac1 (K186E) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Defective for PIP5K binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane and cytoplasm </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-CAAX </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Prenylated mCFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-CAAX </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Prenylated mYFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective; missing PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis defective; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and nucleus </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) (K186E) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective; defective for PIP5K binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane and cytoplasm </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (G12V) (K186E) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; defective for PIP5K binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (G12V) (K186E) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; defective for PIP5K binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (G12V) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (G12V) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis defective; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (G12V) (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (G12V) (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (WT) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> HA-mYFP-Rac1 (WT) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Missing PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and nucleus </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (R66A) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Defective for RhoGDI binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Predominantly membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP-Rac1 (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP-Rac1 (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated mCFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated mYFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr></tbody>
###xml 42 2830 42 2830 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="left" valign="bottom"><bold>Constructions</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Properties</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Predicted localization</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (WT) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-Rac1 (WT) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-Rac1 (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Missing Rac1 PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (R66A) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Defective for RhoGDI binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Predominantly membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Nucleus and cytoplasm </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-Rac1 (K186E) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Defective for PIP5K binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane and cytoplasm </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-CAAX </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Prenylated mCFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-CAAX </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Prenylated mYFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective; missing PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis defective; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and nucleus </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) (K186E) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective; defective for PIP5K binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane and cytoplasm </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (G12V) (K186E) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; defective for PIP5K binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (G12V) (K186E) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; defective for PIP5K binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (G12V) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (G12V) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis defective; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (G12V) (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (G12V) (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (WT) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> HA-mYFP-Rac1 (WT) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Missing PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and nucleus </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (R66A) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Defective for RhoGDI binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Predominantly membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP-Rac1 (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP-Rac1 (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated mCFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated mYFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr></tbody></table>
###xml 0 2830 0 2830 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tbl1"><label>TABLE 1</label><caption><p textid="19"><bold>Rac1 derivatives used in this study</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="left" valign="bottom"><bold>Constructions</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Properties</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Predicted localization</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (WT) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-Rac1 (WT) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-Rac1 (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Missing Rac1 PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (R66A) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Defective for RhoGDI binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Predominantly membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Nucleus and cytoplasm </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-Rac1 (K186E) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Defective for PIP5K binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane and cytoplasm </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-CAAX </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Prenylated mCFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mYFP-CAAX </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Prenylated mYFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective; missing PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis defective; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and nucleus </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> mCFP-Rac1 (G12V) (K186E) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective; defective for PIP5K binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane and cytoplasm </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (G12V) (K186E) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; defective for PIP5K binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (G12V) (K186E) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; defective for PIP5K binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (G12V) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (G12V) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis defective; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mCFP-Rac1 (G12V) (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-mYFP-Rac1 (G12V) (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; GTP hydrolysis-defective; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (WT) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> HA-mYFP-Rac1 (WT) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Wild type </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Missing PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> GTP hydrolysis-defective; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Cytoplasm and nucleus </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Myc-mCFP-Rac1 (R66A) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Defective for RhoGDI binding </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Predominantly membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP-Rac1 (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP-Rac1 (6Q) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP-Rac1 (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR; missing prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP-Rac1 (6Q) (C189S) </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated; missing PBR and prenylation site </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-Myc-mCFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated mCFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> Lyn-HA-mYFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Myristoylated mYFP </td><td colspan="1" rowspan="1" align="left" valign="bottom"> Membrane </td></tr></tbody></table></table-wrap>
TABLE 1Rac1 derivatives used in this studyConstructionsPropertiesPredicted localization mCFP-Rac1 (WT)  Wild type  Cytoplasm and membrane  mYFP-Rac1 (WT)  Wild type  Cytoplasm and membrane  mYFP-Rac1 (6Q)  Missing Rac1 PBR  Cytoplasm  mCFP-Rac1 (G12V)  GTP hydrolysis-defective  Cytoplasm and membrane  mCFP-Rac1 (R66A)  Defective for RhoGDI binding  Predominantly membrane  mCFP-Rac1 (C189S)  Missing prenylation site  Nucleus and cytoplasm  mYFP-Rac1 (K186E)  Defective for PIP5K binding  Membrane and cytoplasm  mCFP-CAAX  Prenylated mCFP  Membrane  mYFP-CAAX  Prenylated mYFP  Membrane  mCFP-Rac1 (G12V) (6Q)  GTP hydrolysis-defective; missing PBR  Cytoplasm  mCFP-Rac1 (G12V) (C189S)  GTP hydrolysis defective; missing prenylation site  Cytoplasm and nucleus  mCFP-Rac1 (G12V) (K186E)  GTP hydrolysis-defective; defective for PIP5K binding  Membrane and cytoplasm  Lyn-mCFP-Rac1 (6Q) (C189S)  Myristoylated; missing PBR and prenylation site  Membrane  Lyn-mCFP-Rac1 (C189S)  Myristoylated; missing prenylation site  Membrane  Lyn-mYFP-Rac1 (C189S)  Myristoylated; missing prenylation site  Membrane  Lyn-mCFP-Rac1 (G12V) (K186E)  Myristoylated; GTP hydrolysis-defective; defective for PIP5K binding  Membrane  Lyn-mYFP-Rac1 (G12V) (K186E)  Myristoylated; GTP hydrolysis-defective; defective for PIP5K binding  Membrane  Lyn-mYFP-Rac1 (G12V) (C189S)  Myristoylated; GTP hydrolysis-defective; missing prenylation site  Membrane  Lyn-mCFP-Rac1 (G12V) (C189S)  Myristoylated; GTP hydrolysis defective; missing prenylation site  Membrane  Lyn-mCFP-Rac1 (6Q) (C189S)  Myristoylated; missing PBR and prenylation site  Membrane  Lyn-mYFP-Rac1 (6Q) (C189S)  Myristoylated; missing PBR and prenylation site  Membrane  Lyn-mCFP-Rac1 (G12V) (6Q) (C189S)  Myristoylated; GTP hydrolysis-defective; missing PBR and prenylation site  Membrane  Lyn-mYFP-Rac1 (G12V) (6Q) (C189S)  Myristoylated; GTP hydrolysis-defective; missing PBR and prenylation site  Membrane  Myc-mCFP-Rac1 (WT)  Wild type  Cytoplasm and membrane  HA-mYFP-Rac1 (WT)  Wild type  Cytoplasm and membrane  Myc-mCFP-Rac1 (6Q)  Missing PBR  Cytoplasm  Myc-mCFP-Rac1 (C189S)  GTP hydrolysis-defective; missing prenylation site  Cytoplasm and nucleus  Myc-mCFP-Rac1 (R66A)  Defective for RhoGDI binding  Predominantly membrane  Lyn-Myc-mCFP-Rac1 (6Q)  Myristoylated; missing PBR  Membrane  Lyn-HA-mYFP-Rac1 (6Q)  Myristoylated; missing PBR  Membrane  Lyn-HA-mYFP-Rac1 (C189S)  Myristoylated; missing prenylation site  Membrane  Lyn-Myc-mCFP-Rac1 (C189S)  Myristoylated; missing prenylation site  Membrane  Lyn-HA-mYFP-Rac1 (6Q) (C189S)  Myristoylated; missing PBR; missing prenylation site  Membrane  Lyn-Myc-mCFP-Rac1 (6Q) (C189S)  Myristoylated; missing PBR and prenylation site  Membrane  Lyn-Myc-mCFP  Myristoylated mCFP  Membrane  Lyn-HA-mYFP  Myristoylated mYFP  Membrane
###end p 18
###begin p 19
###xml 0 35 0 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rac1 derivatives used in this study</bold>
Rac1 derivatives used in this study
###end p 19
###begin p 20
###xml 0 121 0 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Culture of Y. pseudotuberculosis Infection of Mammalian Cells and Immunofluorescence Protection Assay of Bacterial Uptake</italic>
###xml 171 192 171 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis</italic>
###xml 200 201 200 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 298 319 298 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis</italic>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 508 509 508 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 638 642 638 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopT</italic>
###xml 653 657 653 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yopE</italic>
###xml 659 667 659 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">kan yopH</italic>
###xml 669 672 669 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cam</italic>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 11 32 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
###xml 171 198 <span type="species:ncbi:502800">Y. pseudotuberculosis YPIII</span>
###xml 298 319 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
Culture of Y. pseudotuberculosis Infection of Mammalian Cells and Immunofluorescence Protection Assay of Bacterial Uptake-Conditions for growth of virulence plasmid-cured Y. pseudotuberculosis YPIII(p-) with or without YopE or YopT and infection of COS1 have been described (22). The plasmid-cured Y. pseudotuberculosis strain lacks the virulence plasmid (pYV) that encodes YopE and YopT and is efficiently internalized into host cells. Strains that harbor the YopE Rho family GAP (22) or the YopT family CAAX protease (kind gift of Dr. James Bliska, SUNY Stony Brook) contain plasmids encoding these proteins as well as the plasmid pYV (yopT-deficient yopE::kan yopH::cam; referred to as strain YP17) to allow translocation of these proteins via the bacterial type III secretion system (22).
###end p 20
###begin p 21
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 138 139 132 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 139 142 133 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 203 205 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 364 365 352 353 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 370 371 358 359 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 450 451 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 451 454 432 435 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 596 597 571 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 723 724 698 699 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 740 741 712 713 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
For bacteria lacking the virulence plasmid, the YPIII(p-) strain was grown logarithmically in Luria Bertani broth at 26 degreesC until an A600 of 0.7, prior to inoculation onto cultured mammalian cells (22). For strains harboring the pYV plasmid and Yop-encoding plasmids, bacteria were grown with aeration at 26 degreesC overnight in broth supplemented with 2.5 mm CaCl2 and 100 mug/ml ampicillin and then subcultured and grown at 26 degreesC until A600 of 0.2. At this point, the cultures were shifted to 37 degreesC and aerated for 1 h. A multiplicity of infection of 50:1 was used for YPIII(p-) incubations, and a multiplicity of infection of 25:1 was used for other derivatives. For the pYopE-expressing plasmid, 0.1 mm isopropyl-beta-d-thiogalactopyranoside was supplemented during infection to induce YopE expression.
###end p 21
###begin p 22
###xml 79 80 79 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 345 346 339 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 448 469 442 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis</italic>
###xml 649 650 643 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 448 469 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
Bacterial uptake was assayed using immunofluorescence protection as described (6). Briefly, bacteria appropriately cultured were incubated with transfected cells for 30 min at a multiplicity of infection of 50 at 37 degreesC. After incubation, the adherent cells were analyzed for internalized or surface-bound bacteria as described previously (6). The monolayers were fixed in 3% paraformaldehyde and probed with primary antibody directed against Y. pseudotuberculosis, followed by a fluorescent secondary antibody (anti-IgG conjugated to either Alexa Fluor 594 or Cascade Blue) to detect extracellular bacteria. The cells were then permeabilized (2) and probed with antibodies directed against the bacteria to allow detection of both intracellular and extracellular bacteria. The coverslips were then probed with appropriate secondary antibodies to detect intracellular bacteria.
###end p 22
###begin p 23
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRET Measurements</italic>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 906 908 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 1068 1070 1068 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
FRET Measurements-The basis of the assay is that association between Rac1 derivatives fused to either monomeric CFP or monomeric YFP should be detected as a FRET readout. COS1 cells were first transfected with a combination of various derivatives of mCFP-Rac1 and mYFP-Rac1 and then challenged with bacteria. Infections were stopped by fixation after 30 min. The cells were then imaged and analyzed for sensitized FRET from CFP to YFP essentially as described (22), using correction factors for CFP (0.32) and YFP (0.18) for bleed-through from CFP emission and cross-YFP excitation by the FRET filter set. To measure FRET, images from YFP, CFP, and FRET filter sets (22) were captured, choosing regions of interest about nascent phagosomes. Sensitized FRET was then calculated from these regions, by subtracting the CFP and YFP correction factors, using exactly the same procedure as described previously (22). FRET signals were normalized by combination of mCFP and mYFP emissions calculated from the CFP and YFP filter sets using the following formula as described (25).
###end p 23
###begin p 24
###xml 0 72 0 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Determination of mYFP-Rac1 Expression Levels Relative to Endogenous Rac1</italic>
Determination of mYFP-Rac1 Expression Levels Relative to Endogenous Rac1-COS1 cells were transfected with mYFP-Rac1 and cultured overnight. Transfected cells were lifted and subjected to flow cytometry using YFP fluorescence to sort cells into four fractions according to levels of fluorescence (YFP negative, low, medium, and high). A portion of the sorted cells were plated onto fibronectin-coated coverslips, allowed to adhere for approximately3 h, fixed in 4% paraformaldehyde, and imaged to quantify YFP fluorescence. YFP fluorescence quantification was performed as described above for FRET experiments. The remaining sorted cells were lysed in sample buffer; lysates were resolved by SDS-PAGE, blotted, and probed for Rac1 using a monoclonal anti-Rac1 antibody (clone 23A8; Sigma).
###end p 24
###begin p 25
###xml 0 54 0 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Immunoprecipitation of Myc/HA-tagged mCFP/mYFP Fusions</italic>
###xml 271 272 269 270 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 292 293 290 291 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 743 744 727 728 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 763 764 747 748 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 769 770 753 754 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 776 777 760 761 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1091 1097 <span type="species:ncbi:9986">rabbit</span>
###xml 1198 1204 <span type="species:ncbi:9986">rabbit</span>
Immunoprecipitation of Myc/HA-tagged mCFP/mYFP Fusions-293T cells were transfected with 0.5 mug of each plasmid in 6-well dishes. Bait constructs were Myc-tagged, and prey constructs were HA-tagged. Cells were lysed 24 h post-transfection in 500 mul of lysis buffer (20 mm Tris, pH 7.5, 150 mm NaCl, 1% Nonidet P-40, and complete protease inhibitor mixture (Roche Applied Science)). Lysates were then incubated at 4 degreesC (with agitation) for 10 min and spun to remove debris. 50 mul of the cleared lysates was saved as the input fraction, and 400 mul was applied to washed anti-HA epitope affinity resin (monoclonal anti-HA; Sigma) and incubated at 4 degreesC (with agitation) for 1 h. The resin was washed three times in wash buffer (25 mm Tris, pH 7.5, 30 mm MgCl2, 40 mm NaCl, 0.1% Nonidet P-40), and bound proteins were eluted in 100 mul of sample buffer. 10 mul of eluted proteins (immunoprecipitate) as well as 10 mul of cleared lysates (input) were analyzed by SDS-PAGE and Western blotting. Input and immunoprecipitated proteins were detected using an anti-Myc epitope antibody (rabbit polyclonal; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) as well as an anti-HA epitope antibody (rabbit polyclonal; Santa Cruz Biotechnology).
###end p 25
###begin title 26
RESULTS
###end title 26
###begin p 27
###xml 0 38 0 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rac1 Self-associates in Cultured Cells</italic>
###xml 39 60 39 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis</italic>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 180 201 180 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis</italic>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 298 306 298 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 457 458 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 451 458 451 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 712 713 712 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 706 713 706 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 866 867 866 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 872 873 872 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 858 873 858 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, <italic>B</italic> and <italic>C</italic></xref>
###xml 1077 1078 1077 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1071 1078 1071 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 1080 1086 1080 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 39 60 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
###xml 180 201 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
Rac1 Self-associates in Cultured Cells-Y. pseudotuberculosis employs a variety of proteins to activate and misregulate Rac1 in host cells (22). In this report, we examined whether Y. pseudotuberculosis could also control self-association of Rac1 (21). Previously, self-association was demonstrated in vitro by gel filtration chromatography and immunoprecipitation of differentially tagged Rac1 derivatives in an event requiring the COOH-terminal PBR (Fig. 1A) (21). To determine if self-association occurs in cells and can be detected at spatially distinct sites within the cell, Rac1 self-association was analyzed by a FRET-based system, using monomeric CFP and YFP derivatives (mCFP-Rac1 and mYFP-Rac1) (Fig. 1C). When coexpressed in the same cells, mCFP-Rac1(WT) and mYFP-Rac1(WT) produced FRET throughout the cells in all regions except for the nucleus (Fig. 1, B and C). When normalized to the concentration of Rac1 at individual sites in the cell, FRET signals (normalized FRET) were notably stronger at membrane ruffles, indicating enhanced Rac1 self-association (Fig. 1C, arrows). These elevated FRET levels were specific to these sites, because at regions where no ruffles were evident, the lower levels of normalized FRET were independent of Rac1 concentrations.
###end p 27
###begin p 28
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 9 96 9 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rac1 self-association requires determinants important for plasma membrane localization.</bold>
###xml 96 97 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 148 151 148 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SW1</italic>
###xml 156 159 156 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SW2</italic>
###xml 196 198 196 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">12</sup>
###xml 200 203 200 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G12</italic>
###xml 209 211 209 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">66</sup>
###xml 213 216 213 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R66</italic>
###xml 226 229 226 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">186</sup>
###xml 361 367 357 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KKRKRK</italic>
###xml 387 397 383 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">underlined</italic>
###xml 403 406 399 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">189</sup>
###xml 408 412 404 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C189</italic>
###xml 455 456 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 587 588 583 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 859 862 855 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C-G</italic>
###xml 864 868 860 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 993 994 989 990 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1029 1047 1025 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink">schematic diagrams</italic>
###xml 1127 1131 1123 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 1262 1267 1258 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Right</italic>
###xml 1478 1488 1474 1484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sens. FRET</italic>
###xml 1556 1566 1552 1562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">norm. FRET</italic>
###xml 1723 1752 1719 1748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">color gradient look-up tables</italic>
###xml 1775 1791 1771 1787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scale bars below</italic>
###xml 1797 1802 1793 1798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel</italic>
###xml 1808 1814 1804 1810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 1894 1909 1890 1905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White scale bar</italic>
###xml 1913 1914 1909 1910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1939 1945 1934 1940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels</italic>
###xml 9 1947 9 1942 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="29"><bold>Rac1 self-association requires determinants important for plasma membrane localization.</bold><italic>A</italic>, schematic of Rac1 derivatives used in this work. <italic>SW1</italic> and <italic>SW2</italic>, Switch I and Switch II regions. Gly<sup>12</sup> (<italic>G12</italic>), Arg<sup>66</sup> (<italic>R66</italic>), and Lys<sup>186</sup> (K186) are the sites of constitutively active, RhoGDI binding-defective, and PIP5K&#945; binding-defective mutations, respectively. <italic>KKRKRK</italic>, polybasic region (<italic>underlined</italic>). Cys<sup>189</sup> (<italic>C189</italic>) is the site of Rac1 geranylgeranylation. <italic>B</italic>, reduced self-association in the absence of membrane localization or loss of the PBR. The mCFP- or mYFP-Rac1 derivatives noted in <italic>B</italic> were cotransfected into COS1 cells, and FRET measurements were determined (see &#8220;Materials and Methods&#8221;). Sensitized FRET from 20 regions of interest (see &#8220;Materials and Methods&#8221;) were plotted as a function of the intensity of the mCFP-Rac1 donor and mYFP-Rac1 acceptor. <italic>C-G</italic>, <italic>left</italic>, schematic diagrams for detecting Rac1-Rac1 self-association using FRET. Monomeric forms of CFP and YFP were fused to the NH<sub>2</sub> terminus of Rac1, as displayed in <italic>schematic diagrams</italic>. Derivatives in which mYFP-Rac1 is defective for plasma membrane localization (<italic>e.g.</italic> Rac1 6Q and Rac1 C189S) are defective for interaction with wild-type Rac1 on the plasma membrane and thus failed to produce FRET. <italic>Right</italic>, COS1 cells were transfected with mCFP-Rac1 and mYFP-Rac1 having the indicated mutations. The cells were fixed and analyzed by FRET using fluorescence microscopy (see &#8220;Materials and Methods&#8221;). Sensitized FRET (<italic>sens. FRET</italic>) corresponds to the total amount of FRET, whereas normalized FRET (<italic>norm. FRET</italic>) corresponds to the amount of FRET per unit of fluorescent protein (see &#8220;Materials and Methods&#8221;). Both sensitized FRET and normalized FRET are displayed as <italic>color gradient look-up tables</italic>, with the appropriate <italic>scale bars below</italic> each <italic>panel</italic>. The <italic>arrows</italic> indicate membrane ruffles that were concentrated at sites of Rac1 recruitment. <italic>White scale bar</italic> in <italic>G</italic>, 10 &#956;m (applies to all <italic>panels</italic>).</p>
###xml 9 1947 9 1942 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="29"><bold>Rac1 self-association requires determinants important for plasma membrane localization.</bold><italic>A</italic>, schematic of Rac1 derivatives used in this work. <italic>SW1</italic> and <italic>SW2</italic>, Switch I and Switch II regions. Gly<sup>12</sup> (<italic>G12</italic>), Arg<sup>66</sup> (<italic>R66</italic>), and Lys<sup>186</sup> (K186) are the sites of constitutively active, RhoGDI binding-defective, and PIP5K&#945; binding-defective mutations, respectively. <italic>KKRKRK</italic>, polybasic region (<italic>underlined</italic>). Cys<sup>189</sup> (<italic>C189</italic>) is the site of Rac1 geranylgeranylation. <italic>B</italic>, reduced self-association in the absence of membrane localization or loss of the PBR. The mCFP- or mYFP-Rac1 derivatives noted in <italic>B</italic> were cotransfected into COS1 cells, and FRET measurements were determined (see &#8220;Materials and Methods&#8221;). Sensitized FRET from 20 regions of interest (see &#8220;Materials and Methods&#8221;) were plotted as a function of the intensity of the mCFP-Rac1 donor and mYFP-Rac1 acceptor. <italic>C-G</italic>, <italic>left</italic>, schematic diagrams for detecting Rac1-Rac1 self-association using FRET. Monomeric forms of CFP and YFP were fused to the NH<sub>2</sub> terminus of Rac1, as displayed in <italic>schematic diagrams</italic>. Derivatives in which mYFP-Rac1 is defective for plasma membrane localization (<italic>e.g.</italic> Rac1 6Q and Rac1 C189S) are defective for interaction with wild-type Rac1 on the plasma membrane and thus failed to produce FRET. <italic>Right</italic>, COS1 cells were transfected with mCFP-Rac1 and mYFP-Rac1 having the indicated mutations. The cells were fixed and analyzed by FRET using fluorescence microscopy (see &#8220;Materials and Methods&#8221;). Sensitized FRET (<italic>sens. FRET</italic>) corresponds to the total amount of FRET, whereas normalized FRET (<italic>norm. FRET</italic>) corresponds to the amount of FRET per unit of fluorescent protein (see &#8220;Materials and Methods&#8221;). Both sensitized FRET and normalized FRET are displayed as <italic>color gradient look-up tables</italic>, with the appropriate <italic>scale bars below</italic> each <italic>panel</italic>. The <italic>arrows</italic> indicate membrane ruffles that were concentrated at sites of Rac1 recruitment. <italic>White scale bar</italic> in <italic>G</italic>, 10 &#956;m (applies to all <italic>panels</italic>).</p></caption>
###xml 1947 1947 1942 1942 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0030960620001"/>
###xml 0 1947 0 1942 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="29"><bold>Rac1 self-association requires determinants important for plasma membrane localization.</bold><italic>A</italic>, schematic of Rac1 derivatives used in this work. <italic>SW1</italic> and <italic>SW2</italic>, Switch I and Switch II regions. Gly<sup>12</sup> (<italic>G12</italic>), Arg<sup>66</sup> (<italic>R66</italic>), and Lys<sup>186</sup> (K186) are the sites of constitutively active, RhoGDI binding-defective, and PIP5K&#945; binding-defective mutations, respectively. <italic>KKRKRK</italic>, polybasic region (<italic>underlined</italic>). Cys<sup>189</sup> (<italic>C189</italic>) is the site of Rac1 geranylgeranylation. <italic>B</italic>, reduced self-association in the absence of membrane localization or loss of the PBR. The mCFP- or mYFP-Rac1 derivatives noted in <italic>B</italic> were cotransfected into COS1 cells, and FRET measurements were determined (see &#8220;Materials and Methods&#8221;). Sensitized FRET from 20 regions of interest (see &#8220;Materials and Methods&#8221;) were plotted as a function of the intensity of the mCFP-Rac1 donor and mYFP-Rac1 acceptor. <italic>C-G</italic>, <italic>left</italic>, schematic diagrams for detecting Rac1-Rac1 self-association using FRET. Monomeric forms of CFP and YFP were fused to the NH<sub>2</sub> terminus of Rac1, as displayed in <italic>schematic diagrams</italic>. Derivatives in which mYFP-Rac1 is defective for plasma membrane localization (<italic>e.g.</italic> Rac1 6Q and Rac1 C189S) are defective for interaction with wild-type Rac1 on the plasma membrane and thus failed to produce FRET. <italic>Right</italic>, COS1 cells were transfected with mCFP-Rac1 and mYFP-Rac1 having the indicated mutations. The cells were fixed and analyzed by FRET using fluorescence microscopy (see &#8220;Materials and Methods&#8221;). Sensitized FRET (<italic>sens. FRET</italic>) corresponds to the total amount of FRET, whereas normalized FRET (<italic>norm. FRET</italic>) corresponds to the amount of FRET per unit of fluorescent protein (see &#8220;Materials and Methods&#8221;). Both sensitized FRET and normalized FRET are displayed as <italic>color gradient look-up tables</italic>, with the appropriate <italic>scale bars below</italic> each <italic>panel</italic>. The <italic>arrows</italic> indicate membrane ruffles that were concentrated at sites of Rac1 recruitment. <italic>White scale bar</italic> in <italic>G</italic>, 10 &#956;m (applies to all <italic>panels</italic>).</p></caption><graphic xlink:href="zbc0030960620001"/></fig>
FIGURE 1.Rac1 self-association requires determinants important for plasma membrane localization.A, schematic of Rac1 derivatives used in this work. SW1 and SW2, Switch I and Switch II regions. Gly12 (G12), Arg66 (R66), and Lys186 (K186) are the sites of constitutively active, RhoGDI binding-defective, and PIP5Kalpha binding-defective mutations, respectively. KKRKRK, polybasic region (underlined). Cys189 (C189) is the site of Rac1 geranylgeranylation. B, reduced self-association in the absence of membrane localization or loss of the PBR. The mCFP- or mYFP-Rac1 derivatives noted in B were cotransfected into COS1 cells, and FRET measurements were determined (see "Materials and Methods"). Sensitized FRET from 20 regions of interest (see "Materials and Methods") were plotted as a function of the intensity of the mCFP-Rac1 donor and mYFP-Rac1 acceptor. C-G, left, schematic diagrams for detecting Rac1-Rac1 self-association using FRET. Monomeric forms of CFP and YFP were fused to the NH2 terminus of Rac1, as displayed in schematic diagrams. Derivatives in which mYFP-Rac1 is defective for plasma membrane localization (e.g. Rac1 6Q and Rac1 C189S) are defective for interaction with wild-type Rac1 on the plasma membrane and thus failed to produce FRET. Right, COS1 cells were transfected with mCFP-Rac1 and mYFP-Rac1 having the indicated mutations. The cells were fixed and analyzed by FRET using fluorescence microscopy (see "Materials and Methods"). Sensitized FRET (sens. FRET) corresponds to the total amount of FRET, whereas normalized FRET (norm. FRET) corresponds to the amount of FRET per unit of fluorescent protein (see "Materials and Methods"). Both sensitized FRET and normalized FRET are displayed as color gradient look-up tables, with the appropriate scale bars below each panel. The arrows indicate membrane ruffles that were concentrated at sites of Rac1 recruitment. White scale bar in G, 10 mum (applies to all panels).
###end p 28
###begin p 29
###xml 0 87 0 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rac1 self-association requires determinants important for plasma membrane localization.</bold>
###xml 87 88 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 139 142 139 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SW1</italic>
###xml 147 150 147 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SW2</italic>
###xml 187 189 187 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">12</sup>
###xml 191 194 191 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G12</italic>
###xml 200 202 200 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">66</sup>
###xml 204 207 204 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R66</italic>
###xml 217 220 217 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">186</sup>
###xml 352 358 348 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KKRKRK</italic>
###xml 378 388 374 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">underlined</italic>
###xml 394 397 390 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">189</sup>
###xml 399 403 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C189</italic>
###xml 446 447 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 578 579 574 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 850 853 846 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C-G</italic>
###xml 855 859 851 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 984 985 980 981 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1020 1038 1016 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink">schematic diagrams</italic>
###xml 1118 1122 1114 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 1253 1258 1249 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Right</italic>
###xml 1469 1479 1465 1475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sens. FRET</italic>
###xml 1547 1557 1543 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">norm. FRET</italic>
###xml 1714 1743 1710 1739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">color gradient look-up tables</italic>
###xml 1766 1782 1762 1778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scale bars below</italic>
###xml 1788 1793 1784 1789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel</italic>
###xml 1799 1805 1795 1801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 1885 1900 1881 1896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White scale bar</italic>
###xml 1904 1905 1900 1901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1930 1936 1925 1931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels</italic>
Rac1 self-association requires determinants important for plasma membrane localization.A, schematic of Rac1 derivatives used in this work. SW1 and SW2, Switch I and Switch II regions. Gly12 (G12), Arg66 (R66), and Lys186 (K186) are the sites of constitutively active, RhoGDI binding-defective, and PIP5Kalpha binding-defective mutations, respectively. KKRKRK, polybasic region (underlined). Cys189 (C189) is the site of Rac1 geranylgeranylation. B, reduced self-association in the absence of membrane localization or loss of the PBR. The mCFP- or mYFP-Rac1 derivatives noted in B were cotransfected into COS1 cells, and FRET measurements were determined (see "Materials and Methods"). Sensitized FRET from 20 regions of interest (see "Materials and Methods") were plotted as a function of the intensity of the mCFP-Rac1 donor and mYFP-Rac1 acceptor. C-G, left, schematic diagrams for detecting Rac1-Rac1 self-association using FRET. Monomeric forms of CFP and YFP were fused to the NH2 terminus of Rac1, as displayed in schematic diagrams. Derivatives in which mYFP-Rac1 is defective for plasma membrane localization (e.g. Rac1 6Q and Rac1 C189S) are defective for interaction with wild-type Rac1 on the plasma membrane and thus failed to produce FRET. Right, COS1 cells were transfected with mCFP-Rac1 and mYFP-Rac1 having the indicated mutations. The cells were fixed and analyzed by FRET using fluorescence microscopy (see "Materials and Methods"). Sensitized FRET (sens. FRET) corresponds to the total amount of FRET, whereas normalized FRET (norm. FRET) corresponds to the amount of FRET per unit of fluorescent protein (see "Materials and Methods"). Both sensitized FRET and normalized FRET are displayed as color gradient look-up tables, with the appropriate scale bars below each panel. The arrows indicate membrane ruffles that were concentrated at sites of Rac1 recruitment. White scale bar in G, 10 mum (applies to all panels).
###end p 29
###begin p 30
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 295 296 295 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 301 302 301 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 287 302 287 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, <italic>B</italic> and <italic>D</italic></xref>
###xml 304 306 304 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6Q</italic>
###xml 396 404 396 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
Consistent with biochemical data, self-association of Rac1, as detected by FRET, required the presence of the PBR on both partners. Co-transfection of mCFP-Rac1(WT) with mYFP-Rac1(6Q), which has each of the basic residues in the PBR replaced with Gln (26), produced a lower FRET signal (Fig. 1, B and D; 6Q), confirming the previous published findings that the PBR mediates Rac1 self-association in vitro (21).
###end p 30
###begin p 31
###xml 0 64 0 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Self-association Is Not Due to Overexpression of Rac1 Constructs</italic>
###xml 536 537 536 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 530 537 530 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 776 779 776 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neg</italic>
###xml 781 792 781 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lo, med, hi</italic>
###xml 800 801 800 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 794 801 794 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
Self-association Is Not Due to Overexpression of Rac1 Constructs-Since any self-association observed by FRET could result from aggregation of overexpressed protein, the concentration of Rac1 expressed from the transfected plasmids relative to endogenous levels of Rac1 was determined. COS1 cells were transfected with mYFP-Rac1 and sorted by flow cytometry to determine the concentration of Rac1 relative to the amount of YFP fluorescence observed by microscopy. The transfected cells showed a broad distribution of fluorescence (Fig. 2A), with a peak of untransfected cells and a shoulder of cells having increasing amounts of fluorescence. The total cell population was collected into four separate fractions consisting of cells with increasing amounts of YFP fluorescence (neg, lo, med, hi; Fig. 2A), and each population was analyzed to determine the amount of mYFP-Rac1 expression as well as the level of fluorescence using our standard microscopic techniques.
###end p 31
###begin p 32
###xml 240 241 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 234 241 234 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 243 249 243 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YFP lo</italic>
###xml 299 300 299 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 293 300 293 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 302 309 302 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YFP med</italic>
###xml 314 320 314 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YFP hi</italic>
###xml 545 546 545 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 551 552 551 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 537 552 537 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, <italic>C</italic> and <italic>D</italic></xref>
###xml 562 575 562 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lo versus med</italic>
###xml 751 752 739 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 745 752 733 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 827 828 815 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 821 828 809 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 830 845 818 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mYFP-Rac1(FRET)</italic>
###xml 1002 1003 990 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 996 1003 984 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 1005 1008 993 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">med</italic>
The expression of mYFP-Rac1 in the YFP-lo fraction was lower than that of endogenous Rac1, based on Western blotting with anti-Rac1 antibody. The levels of mYFP-Rac1 were about 50% of the levels of endogenous Rac1 in this population (Fig. 2B; YFP lo). In contrast, the other sorted fractions (Fig. 2B; YFP med and YFP hi) expressed much higher levels of YFP-Rac1 compared with endogenous Rac1. Transfectants plated onto coverslips from the YFP-lo population clearly had fluorescence levels similar to those being used for FRET analysis (Fig. 2, C and D; compare lo versus med). When the fluorescence was determined on individual cells from the mYFP-lo fraction, the average intensity of individual cells was approximately500 fluorescence units (Fig. 2D), which is about the mean intensity of all the cells used for FRET (Fig. 2D; mYFP-Rac1(FRET)). In fact, the cell populations that showed overexpression of YFP-Rac1 gave fluorescence intensities that were well beyond what was analyzed by FRET (Fig. 2D; med). Therefore, a large proportion of the cells analyzed by FRET expressed amounts of mYFP-Rac1 that are at or below endogenous levels of Rac1. We conclude that self-association is not due to overexpression of the fluorescence derivatives.
###end p 32
###begin p 33
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 9 91 9 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink">FRET analysis of Rac1 self-association was performed at physiological Rac1 levels.</bold>
###xml 91 92 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 176 179 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neg</italic>
###xml 200 202 200 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lo</italic>
###xml 213 216 213 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">med</italic>
###xml 229 231 229 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hi</italic>
###xml 235 236 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 337 340 337 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top</italic>
###xml 467 473 467 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom</italic>
###xml 476 477 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 697 700 697 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">med</italic>
###xml 762 764 762 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lo</italic>
###xml 792 805 792 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">look-up table</italic>
###xml 807 822 807 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White scale bar</italic>
###xml 832 833 831 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 9 1133 9 1130 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="34"><bold>FRET analysis of Rac1 self-association was performed at physiological Rac1 levels.</bold><italic>A</italic>, mYFP-Rac1-transfected COS1 cells were sorted according to fluorescence (negative (<italic>neg</italic>), low fluorescence (<italic>lo</italic>), medium (<italic>med</italic>), and high (<italic>hi</italic>)). <italic>B</italic>, sorted cells were lysed and analyzed by Western blotting, probing with a monoclonal Rac1 antibody (<italic>top</italic>). Blots were scanned, and the extent of overexpression with respect to endogenous Rac1 levels was quantified by densitometry (<italic>bottom</italic>). <italic>C</italic>, sorted cells were plated onto fibronectin-coated coverslips and allowed to adhere. YFP fluorescence images were collected from low and medium fluorescence populations. Two representative images are displayed where the <italic>med</italic> image has been normalized to the fluorescence maximum of the <italic>lo</italic> image, as indicated by the <italic>look-up table</italic>. <italic>White scale bar</italic>, 10 &#956;m. <italic>D</italic>, fluorescence intensity of the low and medium fluorescence populations was quantified exactly as the FRET analysis. Data are displayed as average YFP fluorescence &#177; S.E. on a per cell basis. Average YFP fluorescence from a typical FRET experiment is included in this graph for comparison purposes.</p>
###xml 9 1133 9 1130 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="34"><bold>FRET analysis of Rac1 self-association was performed at physiological Rac1 levels.</bold><italic>A</italic>, mYFP-Rac1-transfected COS1 cells were sorted according to fluorescence (negative (<italic>neg</italic>), low fluorescence (<italic>lo</italic>), medium (<italic>med</italic>), and high (<italic>hi</italic>)). <italic>B</italic>, sorted cells were lysed and analyzed by Western blotting, probing with a monoclonal Rac1 antibody (<italic>top</italic>). Blots were scanned, and the extent of overexpression with respect to endogenous Rac1 levels was quantified by densitometry (<italic>bottom</italic>). <italic>C</italic>, sorted cells were plated onto fibronectin-coated coverslips and allowed to adhere. YFP fluorescence images were collected from low and medium fluorescence populations. Two representative images are displayed where the <italic>med</italic> image has been normalized to the fluorescence maximum of the <italic>lo</italic> image, as indicated by the <italic>look-up table</italic>. <italic>White scale bar</italic>, 10 &#956;m. <italic>D</italic>, fluorescence intensity of the low and medium fluorescence populations was quantified exactly as the FRET analysis. Data are displayed as average YFP fluorescence &#177; S.E. on a per cell basis. Average YFP fluorescence from a typical FRET experiment is included in this graph for comparison purposes.</p></caption>
###xml 1133 1133 1130 1130 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0030960620002"/>
###xml 0 1133 0 1130 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="34"><bold>FRET analysis of Rac1 self-association was performed at physiological Rac1 levels.</bold><italic>A</italic>, mYFP-Rac1-transfected COS1 cells were sorted according to fluorescence (negative (<italic>neg</italic>), low fluorescence (<italic>lo</italic>), medium (<italic>med</italic>), and high (<italic>hi</italic>)). <italic>B</italic>, sorted cells were lysed and analyzed by Western blotting, probing with a monoclonal Rac1 antibody (<italic>top</italic>). Blots were scanned, and the extent of overexpression with respect to endogenous Rac1 levels was quantified by densitometry (<italic>bottom</italic>). <italic>C</italic>, sorted cells were plated onto fibronectin-coated coverslips and allowed to adhere. YFP fluorescence images were collected from low and medium fluorescence populations. Two representative images are displayed where the <italic>med</italic> image has been normalized to the fluorescence maximum of the <italic>lo</italic> image, as indicated by the <italic>look-up table</italic>. <italic>White scale bar</italic>, 10 &#956;m. <italic>D</italic>, fluorescence intensity of the low and medium fluorescence populations was quantified exactly as the FRET analysis. Data are displayed as average YFP fluorescence &#177; S.E. on a per cell basis. Average YFP fluorescence from a typical FRET experiment is included in this graph for comparison purposes.</p></caption><graphic xlink:href="zbc0030960620002"/></fig>
FIGURE 2.FRET analysis of Rac1 self-association was performed at physiological Rac1 levels.A, mYFP-Rac1-transfected COS1 cells were sorted according to fluorescence (negative (neg), low fluorescence (lo), medium (med), and high (hi)). B, sorted cells were lysed and analyzed by Western blotting, probing with a monoclonal Rac1 antibody (top). Blots were scanned, and the extent of overexpression with respect to endogenous Rac1 levels was quantified by densitometry (bottom). C, sorted cells were plated onto fibronectin-coated coverslips and allowed to adhere. YFP fluorescence images were collected from low and medium fluorescence populations. Two representative images are displayed where the med image has been normalized to the fluorescence maximum of the lo image, as indicated by the look-up table. White scale bar, 10 mum. D, fluorescence intensity of the low and medium fluorescence populations was quantified exactly as the FRET analysis. Data are displayed as average YFP fluorescence +/- S.E. on a per cell basis. Average YFP fluorescence from a typical FRET experiment is included in this graph for comparison purposes.
###end p 33
###begin p 34
###xml 0 82 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">FRET analysis of Rac1 self-association was performed at physiological Rac1 levels.</bold>
###xml 82 83 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 167 170 167 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neg</italic>
###xml 191 193 191 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lo</italic>
###xml 204 207 204 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">med</italic>
###xml 220 222 220 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hi</italic>
###xml 226 227 226 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 328 331 328 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top</italic>
###xml 458 464 458 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom</italic>
###xml 467 468 467 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 688 691 688 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">med</italic>
###xml 753 755 753 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lo</italic>
###xml 783 796 783 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">look-up table</italic>
###xml 798 813 798 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White scale bar</italic>
###xml 823 824 822 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
FRET analysis of Rac1 self-association was performed at physiological Rac1 levels.A, mYFP-Rac1-transfected COS1 cells were sorted according to fluorescence (negative (neg), low fluorescence (lo), medium (med), and high (hi)). B, sorted cells were lysed and analyzed by Western blotting, probing with a monoclonal Rac1 antibody (top). Blots were scanned, and the extent of overexpression with respect to endogenous Rac1 levels was quantified by densitometry (bottom). C, sorted cells were plated onto fibronectin-coated coverslips and allowed to adhere. YFP fluorescence images were collected from low and medium fluorescence populations. Two representative images are displayed where the med image has been normalized to the fluorescence maximum of the lo image, as indicated by the look-up table. White scale bar, 10 mum. D, fluorescence intensity of the low and medium fluorescence populations was quantified exactly as the FRET analysis. Data are displayed as average YFP fluorescence +/- S.E. on a per cell basis. Average YFP fluorescence from a typical FRET experiment is included in this graph for comparison purposes.
###end p 34
###begin p 35
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 9 82 9 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rac1 plasma membrane localization requires prenylation and an intact PBR.</bold>
###xml 179 180 179 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 197 198 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 263 264 259 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 305 306 301 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 356 357 352 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 389 390 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 418 419 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 427 428 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 527 528 523 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 548 549 544 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 575 576 571 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 581 582 577 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 599 614 595 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White scale bar</italic>
###xml 618 619 614 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 644 650 639 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels</italic>
###xml 9 652 9 647 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="36"><bold>Rac1 plasma membrane localization requires prenylation and an intact PBR.</bold> mYFP-Rac1 fusions were expressed in COS1 cells and imaged microscopically for YFP fluorescence. <italic>A</italic>, mYFP-Rac1(WT); <italic>B</italic>, mYFP-Rac1(K186E), defective for effector (PIP5K&#945;) binding; <italic>C</italic>, mYFP-Rac1(C189S), lacking prenylation; <italic>D</italic>, Lyn-mYFP-Rac1(C189S), myristoylated derivative; <italic>E</italic>, mYFP-Rac1(6Q), defective PBR; <italic>F</italic>, Lyn-mYFP-Rac1(6Q)(C189S); <italic>G</italic>, mYFP; <italic>H</italic>, Lyn-mYFP, myristoylated mYFP. Note that Lyn myristoylation targets proteins localized nuclearly (<italic>C</italic>) or perinuclearly (<italic>E</italic>) to the plasma membrane (<italic>F</italic> and <italic>H</italic>, respectively). <italic>White scale bar</italic> in <italic>H</italic>, 20 &#956;m (applies to all <italic>panels</italic>).</p>
###xml 9 652 9 647 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="36"><bold>Rac1 plasma membrane localization requires prenylation and an intact PBR.</bold> mYFP-Rac1 fusions were expressed in COS1 cells and imaged microscopically for YFP fluorescence. <italic>A</italic>, mYFP-Rac1(WT); <italic>B</italic>, mYFP-Rac1(K186E), defective for effector (PIP5K&#945;) binding; <italic>C</italic>, mYFP-Rac1(C189S), lacking prenylation; <italic>D</italic>, Lyn-mYFP-Rac1(C189S), myristoylated derivative; <italic>E</italic>, mYFP-Rac1(6Q), defective PBR; <italic>F</italic>, Lyn-mYFP-Rac1(6Q)(C189S); <italic>G</italic>, mYFP; <italic>H</italic>, Lyn-mYFP, myristoylated mYFP. Note that Lyn myristoylation targets proteins localized nuclearly (<italic>C</italic>) or perinuclearly (<italic>E</italic>) to the plasma membrane (<italic>F</italic> and <italic>H</italic>, respectively). <italic>White scale bar</italic> in <italic>H</italic>, 20 &#956;m (applies to all <italic>panels</italic>).</p></caption>
###xml 652 652 647 647 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0030960620003"/>
###xml 0 652 0 647 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="36"><bold>Rac1 plasma membrane localization requires prenylation and an intact PBR.</bold> mYFP-Rac1 fusions were expressed in COS1 cells and imaged microscopically for YFP fluorescence. <italic>A</italic>, mYFP-Rac1(WT); <italic>B</italic>, mYFP-Rac1(K186E), defective for effector (PIP5K&#945;) binding; <italic>C</italic>, mYFP-Rac1(C189S), lacking prenylation; <italic>D</italic>, Lyn-mYFP-Rac1(C189S), myristoylated derivative; <italic>E</italic>, mYFP-Rac1(6Q), defective PBR; <italic>F</italic>, Lyn-mYFP-Rac1(6Q)(C189S); <italic>G</italic>, mYFP; <italic>H</italic>, Lyn-mYFP, myristoylated mYFP. Note that Lyn myristoylation targets proteins localized nuclearly (<italic>C</italic>) or perinuclearly (<italic>E</italic>) to the plasma membrane (<italic>F</italic> and <italic>H</italic>, respectively). <italic>White scale bar</italic> in <italic>H</italic>, 20 &#956;m (applies to all <italic>panels</italic>).</p></caption><graphic xlink:href="zbc0030960620003"/></fig>
FIGURE 3.Rac1 plasma membrane localization requires prenylation and an intact PBR. mYFP-Rac1 fusions were expressed in COS1 cells and imaged microscopically for YFP fluorescence. A, mYFP-Rac1(WT); B, mYFP-Rac1(K186E), defective for effector (PIP5Kalpha) binding; C, mYFP-Rac1(C189S), lacking prenylation; D, Lyn-mYFP-Rac1(C189S), myristoylated derivative; E, mYFP-Rac1(6Q), defective PBR; F, Lyn-mYFP-Rac1(6Q)(C189S); G, mYFP; H, Lyn-mYFP, myristoylated mYFP. Note that Lyn myristoylation targets proteins localized nuclearly (C) or perinuclearly (E) to the plasma membrane (F and H, respectively). White scale bar in H, 20 mum (applies to all panels).
###end p 35
###begin p 36
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rac1 plasma membrane localization requires prenylation and an intact PBR.</bold>
###xml 170 171 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 188 189 188 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 254 255 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 296 297 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 347 348 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 380 381 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 409 410 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 418 419 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 518 519 514 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 539 540 535 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 566 567 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 572 573 568 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 590 605 586 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White scale bar</italic>
###xml 609 610 605 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 635 641 630 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels</italic>
Rac1 plasma membrane localization requires prenylation and an intact PBR. mYFP-Rac1 fusions were expressed in COS1 cells and imaged microscopically for YFP fluorescence. A, mYFP-Rac1(WT); B, mYFP-Rac1(K186E), defective for effector (PIP5Kalpha) binding; C, mYFP-Rac1(C189S), lacking prenylation; D, Lyn-mYFP-Rac1(C189S), myristoylated derivative; E, mYFP-Rac1(6Q), defective PBR; F, Lyn-mYFP-Rac1(6Q)(C189S); G, mYFP; H, Lyn-mYFP, myristoylated mYFP. Note that Lyn myristoylation targets proteins localized nuclearly (C) or perinuclearly (E) to the plasma membrane (F and H, respectively). White scale bar in H, 20 mum (applies to all panels).
###end p 36
###begin p 37
###xml 0 82 0 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasma Membrane Localization of Rac1 Is Not Sufficient to Promote Self-association</italic>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 209 215 209 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 225 226 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 232 233 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 470 471 470 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 583 584 583 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 577 584 577 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 806 807 806 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 812 813 812 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 798 813 798 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, <italic>B</italic> and <italic>E</italic></xref>
###xml 955 957 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 1203 1205 1203 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 1207 1209 1207 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 1374 1375 1374 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1380 1381 1380 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1366 1381 1366 1381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, <italic>B</italic> and <italic>F</italic></xref>
###xml 1383 1387 1383 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R66A</italic>
###xml 1460 1461 1460 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
Plasma Membrane Localization of Rac1 Is Not Sufficient to Promote Self-association-The 6Q mutation that replaces the PBR has the secondary effect of interfering with plasma membrane localization of Rac1 (14) (Fig. 3, compare A with E). We therefore tested whether blocking plasma membrane localization would affect the ability of Rac1 to self-associate. The C189S mutation, immediately downstream of PBR, prevents geranylgeranylation of Rac1 at the carboxyl-terminal CAAX box and resulted in a large pool of the protein localizing in the nucleus, as previously described (27) (Fig. 3C). This lipid modification is essential for the Ras superfamily of small GTPases to anchor onto the plasma membrane (28). Based on the FRET assay, mCFP-Rac1(C189S) showed no ability to interact with mYFP-Rac1(WT) (Fig. 1, B and E; C189S), indicating the importance of plasma membrane localization for Rac1 self-association. The C189S mutation also blocks RhoGDI binding (29), raising the possibility that RhoGDI could play some role in Rac1 self-association. To rule out this possibility, the interaction of the Rac1(R66A) mutant was analyzed, which is unable to bind RhoGDI but maintains plasma membrane localization (22, 30). mCFP-Rac1(R66A) produced FRET with mYFP-Rac1(WT) as efficiently as was observed for the interaction between the fluorescent wild type derivatives of Rac (Fig. 1, B and F; R66A). Thus, plasma membrane localization, but not RhoGDI binding via the CAAX geranylgeranylation site, was necessary for Rac1 self-association.
###end p 37
###begin p 38
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 9 109 9 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The polybasic region is not sufficient to allow Rac1 self-association of membrane-localized protein.</bold>
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 278 279 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 329 330 329 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 429 430 429 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 513 514 513 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 545 546 545 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 655 656 655 656 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 687 688 687 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 754 755 754 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 865 866 865 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1089 1099 1089 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sens. FRET</italic>
###xml 1118 1147 1118 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">color gradient look-up tables</italic>
###xml 1169 1174 1169 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scale</italic>
###xml 1176 1191 1176 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White scale bar</italic>
###xml 1195 1196 1195 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1221 1227 1220 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels</italic>
###xml 9 1229 9 1228 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="39"><bold>The polybasic region is not sufficient to allow Rac1 self-association of membrane-localized protein.</bold> Schematic diagrams on the <italic>left</italic> represent the pairs of fluorescent proteins used for FRET analysis in COS1 cells. Derivatives used were mCFP-Rac1(WT) and mYFP-Rac1(WT) (<italic>A</italic>); the mCFP-GerGer and mYFP-GerGer pair having CAA<italic>X</italic> boxes at the carboxyl termini of the fluorescent proteins, lacking all other Rac1 sequences (<xref ref-type="bibr" rid="ref24">24</xref>) (<italic>B</italic>); Lyn-mCFP and Lyn-mYFP, fluorescent proteins localized in the membrane via the NH<sub>2</sub>-terminal myristoylation site (<italic>C</italic>); Lyn-mCFP-Rac1-6Q(C189S) and Lyn-mYFP-Rac1-6Q(C189S), localizing hybrid proteins in the membrane via the NH<sub>2</sub>-terminal myristoylation site (<italic>D</italic>); and Lyn-mCFP-Rac1(C189S) and Lyn-mYFP-Rac1(C189S), in which CAA<italic>X</italic> box defective mutants with intact PBRs are forced into the plasma membrane by the Lyn myristoylation signal (<italic>E</italic>). Constructs encoding these proteins were transfected into COS1 cells, fixed the day after transfection, and subjected to FRET microscopy. Representative images of the CFP and YFP channels, along with the sensitized FRET (<italic>sens. FRET</italic>) are displayed as <italic>color gradient look-up tables</italic>, using the displayed <italic>scale</italic>. <italic>White scale bar</italic> in <italic>E</italic>, 10 &#956;m (applies to all <italic>panels</italic>).</p>
###xml 9 1229 9 1228 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="39"><bold>The polybasic region is not sufficient to allow Rac1 self-association of membrane-localized protein.</bold> Schematic diagrams on the <italic>left</italic> represent the pairs of fluorescent proteins used for FRET analysis in COS1 cells. Derivatives used were mCFP-Rac1(WT) and mYFP-Rac1(WT) (<italic>A</italic>); the mCFP-GerGer and mYFP-GerGer pair having CAA<italic>X</italic> boxes at the carboxyl termini of the fluorescent proteins, lacking all other Rac1 sequences (<xref ref-type="bibr" rid="ref24">24</xref>) (<italic>B</italic>); Lyn-mCFP and Lyn-mYFP, fluorescent proteins localized in the membrane via the NH<sub>2</sub>-terminal myristoylation site (<italic>C</italic>); Lyn-mCFP-Rac1-6Q(C189S) and Lyn-mYFP-Rac1-6Q(C189S), localizing hybrid proteins in the membrane via the NH<sub>2</sub>-terminal myristoylation site (<italic>D</italic>); and Lyn-mCFP-Rac1(C189S) and Lyn-mYFP-Rac1(C189S), in which CAA<italic>X</italic> box defective mutants with intact PBRs are forced into the plasma membrane by the Lyn myristoylation signal (<italic>E</italic>). Constructs encoding these proteins were transfected into COS1 cells, fixed the day after transfection, and subjected to FRET microscopy. Representative images of the CFP and YFP channels, along with the sensitized FRET (<italic>sens. FRET</italic>) are displayed as <italic>color gradient look-up tables</italic>, using the displayed <italic>scale</italic>. <italic>White scale bar</italic> in <italic>E</italic>, 10 &#956;m (applies to all <italic>panels</italic>).</p></caption>
###xml 1229 1229 1228 1228 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0030960620004"/>
###xml 0 1229 0 1228 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="39"><bold>The polybasic region is not sufficient to allow Rac1 self-association of membrane-localized protein.</bold> Schematic diagrams on the <italic>left</italic> represent the pairs of fluorescent proteins used for FRET analysis in COS1 cells. Derivatives used were mCFP-Rac1(WT) and mYFP-Rac1(WT) (<italic>A</italic>); the mCFP-GerGer and mYFP-GerGer pair having CAA<italic>X</italic> boxes at the carboxyl termini of the fluorescent proteins, lacking all other Rac1 sequences (<xref ref-type="bibr" rid="ref24">24</xref>) (<italic>B</italic>); Lyn-mCFP and Lyn-mYFP, fluorescent proteins localized in the membrane via the NH<sub>2</sub>-terminal myristoylation site (<italic>C</italic>); Lyn-mCFP-Rac1-6Q(C189S) and Lyn-mYFP-Rac1-6Q(C189S), localizing hybrid proteins in the membrane via the NH<sub>2</sub>-terminal myristoylation site (<italic>D</italic>); and Lyn-mCFP-Rac1(C189S) and Lyn-mYFP-Rac1(C189S), in which CAA<italic>X</italic> box defective mutants with intact PBRs are forced into the plasma membrane by the Lyn myristoylation signal (<italic>E</italic>). Constructs encoding these proteins were transfected into COS1 cells, fixed the day after transfection, and subjected to FRET microscopy. Representative images of the CFP and YFP channels, along with the sensitized FRET (<italic>sens. FRET</italic>) are displayed as <italic>color gradient look-up tables</italic>, using the displayed <italic>scale</italic>. <italic>White scale bar</italic> in <italic>E</italic>, 10 &#956;m (applies to all <italic>panels</italic>).</p></caption><graphic xlink:href="zbc0030960620004"/></fig>
FIGURE 4.The polybasic region is not sufficient to allow Rac1 self-association of membrane-localized protein. Schematic diagrams on the left represent the pairs of fluorescent proteins used for FRET analysis in COS1 cells. Derivatives used were mCFP-Rac1(WT) and mYFP-Rac1(WT) (A); the mCFP-GerGer and mYFP-GerGer pair having CAAX boxes at the carboxyl termini of the fluorescent proteins, lacking all other Rac1 sequences (24) (B); Lyn-mCFP and Lyn-mYFP, fluorescent proteins localized in the membrane via the NH2-terminal myristoylation site (C); Lyn-mCFP-Rac1-6Q(C189S) and Lyn-mYFP-Rac1-6Q(C189S), localizing hybrid proteins in the membrane via the NH2-terminal myristoylation site (D); and Lyn-mCFP-Rac1(C189S) and Lyn-mYFP-Rac1(C189S), in which CAAX box defective mutants with intact PBRs are forced into the plasma membrane by the Lyn myristoylation signal (E). Constructs encoding these proteins were transfected into COS1 cells, fixed the day after transfection, and subjected to FRET microscopy. Representative images of the CFP and YFP channels, along with the sensitized FRET (sens. FRET) are displayed as color gradient look-up tables, using the displayed scale. White scale bar in E, 10 mum (applies to all panels).
###end p 38
###begin p 39
###xml 0 100 0 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The polybasic region is not sufficient to allow Rac1 self-association of membrane-localized protein.</bold>
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 269 270 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 320 321 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 420 421 420 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 504 505 504 505 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 536 537 536 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 646 647 646 647 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 678 679 678 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 745 746 745 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 856 857 856 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1080 1090 1080 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sens. FRET</italic>
###xml 1109 1138 1109 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">color gradient look-up tables</italic>
###xml 1160 1165 1160 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scale</italic>
###xml 1167 1182 1167 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White scale bar</italic>
###xml 1186 1187 1186 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1212 1218 1211 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels</italic>
The polybasic region is not sufficient to allow Rac1 self-association of membrane-localized protein. Schematic diagrams on the left represent the pairs of fluorescent proteins used for FRET analysis in COS1 cells. Derivatives used were mCFP-Rac1(WT) and mYFP-Rac1(WT) (A); the mCFP-GerGer and mYFP-GerGer pair having CAAX boxes at the carboxyl termini of the fluorescent proteins, lacking all other Rac1 sequences (24) (B); Lyn-mCFP and Lyn-mYFP, fluorescent proteins localized in the membrane via the NH2-terminal myristoylation site (C); Lyn-mCFP-Rac1-6Q(C189S) and Lyn-mYFP-Rac1-6Q(C189S), localizing hybrid proteins in the membrane via the NH2-terminal myristoylation site (D); and Lyn-mCFP-Rac1(C189S) and Lyn-mYFP-Rac1(C189S), in which CAAX box defective mutants with intact PBRs are forced into the plasma membrane by the Lyn myristoylation signal (E). Constructs encoding these proteins were transfected into COS1 cells, fixed the day after transfection, and subjected to FRET microscopy. Representative images of the CFP and YFP channels, along with the sensitized FRET (sens. FRET) are displayed as color gradient look-up tables, using the displayed scale. White scale bar in E, 10 mum (applies to all panels).
###end p 39
###begin p 40
###xml 182 183 182 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 308 309 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 302 309 302 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>H</italic></xref>
###xml 410 416 410 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 426 427 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 433 434 433 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 439 440 439 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 454 455 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 456 457 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 462 463 462 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 446 463 446 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, <italic>A</italic>-<italic>C</italic> and <italic>I</italic></xref>
###xml 502 503 502 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 508 509 508 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 494 509 494 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, <italic>B</italic> and <italic>C</italic></xref>
###xml 606 627 606 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis</italic>
###xml 789 790 789 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 795 796 795 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 781 796 781 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, <italic>B</italic> and <italic>C</italic></xref>
###xml 606 627 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
To determine whether plasma membrane localization was sufficient to cause intermolecular FRET in this particular assay, we targeted mCFP/mYFP onto the plasma membrane by either an NH2-terminal myristoylation signal from the Lyn protein (24) or the COOH-terminal geranylgeranylation site from Rac1 (see Fig. 3H for Lyn-mYFP localization). Neither of the two tags could enable the CFP/YFP pair to generate FRET (Fig. 4, compare A with B and C; see Fig. 5, A-C and I) even at high concentrations (Fig. 5, B and C). This lowered self-association was observed, in addition, with cells that were challenged with Y. pseudotuberculosis, since no FRET signal could be detected at regions of membrane aggregation resulting from invasin binding or at regions of membrane ruffling (see below; Fig. 7, B and C). We conclude that plasma membrane localization was not sufficient to cause protein self-association.
###end p 40
###begin p 41
###xml 198 204 198 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 214 215 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 221 222 221 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 243 249 243 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 259 260 259 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 266 267 266 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 435 436 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 441 442 441 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 427 442 427 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, <italic>D</italic> and <italic>E</italic></xref>
###xml 456 460 456 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D, E</italic>
###xml 466 467 466 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 448 467 448 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, <italic>D, E</italic>, and <italic>I</italic></xref>
###xml 587 593 587 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 988 992 988 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F, G</italic>
###xml 998 999 998 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 980 999 980 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, <italic>F, G</italic>, and <italic>I</italic></xref>
Forcing plasma membrane localization of proteins that do not interact also was not sufficient to cause protein self-association. The addition of the Lyn myristoylation signal to either Rac1(C189S) (Fig. 3, compare C with D) or Rac1(6Q/C189S) (Fig. 3, compare E with F) resulted in plasma membrane localization of these derivatives. Neither Lyn-modified derivative generated a significant FRET signal for Rac1-Rac1 interaction (Fig. 4, D and E, and Fig. 5, D, E, and I). Therefore, the aberrant localization of these Rac1 derivatives to sites such as the nucleus and perinuclear locales (Fig. 3) does not explain the inability of these proteins to self-associate, since even when they are plasma membrane-localized, they could not self-associate. Additionally, GTPase activation does not cause self-association under these conditions, because constitutively active membrane-targeted Rac1 variants lacking the appropriate carboxyl-terminal sequences fail to generate a FRET signal (Fig. 5, F, G, and I).
###end p 41
###begin p 42
###xml 0 61 0 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lowering Affinity for Effectors Reduces Rac1 Self-association</italic>
###xml 238 239 230 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 241 243 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 496 497 484 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 506 507 494 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 500 507 488 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 604 605 592 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 603 605 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">1<italic>G</italic></xref>
###xml 613 614 601 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 619 620 607 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 610 620 598 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">5, <italic>H</italic> and <italic>I</italic></xref>
###xml 755 758 743 746 <sup xmlns:xlink="http://www.w3.org/1999/xlink">186</sup>
###xml 803 806 791 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink">189</sup>
Lowering Affinity for Effectors Reduces Rac1 Self-association-The PBR has been characterized to have a role in binding effectors, such as phosphatidylinositol-4-phosphate 5-kinase-alpha (PIP5Kalpha) and protein kinase C-related kinase 1 (7, 31). To determine whether disruption of effector recognition reduces Rac1 self-association, we introduced the K186E mutation into Rac1, which has been demonstrated to block the binding of PIP5Kalpha without affecting plasma membrane localization of Rac1 (7) (Fig. 3B). A lower level of mCFP-Rac1(K186E) self-association was observed relative to wild type (Figs. 1G and 5, H and I). Therefore, maximum Rac1 self-association depended on sequence determinants that are also important for effector binding (residue Lys186) as well as geranylgeranylation (residue Cys189).
###end p 42
###begin p 43
###xml 0 95 0 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Formation of a Stable Rac1-Rac1 Complex Requires the Presence of the PBR and Prenylation Signal</italic>
###xml 243 244 243 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 237 244 237 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 764 765 764 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 758 765 758 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 1357 1360 1357 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B-F</italic>
###xml 1349 1360 1349 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, <italic>B-F</italic></xref>
###xml 1522 1525 1522 1525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B-F</italic>
###xml 1514 1525 1514 1525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, <italic>B-F</italic></xref>
###xml 1657 1658 1657 1658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1663 1664 1663 1664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1649 1664 1649 1664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, <italic>B</italic> and <italic>F</italic></xref>
###xml 1666 1668 1666 1668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt</italic>
###xml 1671 1673 1671 1673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6Q</italic>
###xml 1678 1680 1678 1680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wt</italic>
###xml 1683 1688 1683 1688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C189S</italic>
###xml 1774 1775 1774 1775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1780 1781 1780 1781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1766 1781 1766 1781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, <italic>B</italic> and <italic>F</italic></xref>
Formation of a Stable Rac1-Rac1 Complex Requires the Presence of the PBR and Prenylation Signal-To support the data from the FRET assay, an independent test of Rac1 self-association was performed using a coimmunoprecipitation procedure (Fig. 6A). The power of the FRET readout is that it provides spatial information and may allow the detection of transient interactions. If the observed self-association is transient, then it may not survive other detection strategies, such as immunoaffinity techniques, that require slow dissociation rates. To determine if interaction could be observed using more restrictive conditions, several of the constructs used in the microscopic assay were tagged with either Myc or HA epitopes and expressed in mammalian cells (Fig. 6A). For each condition, two constructs were co-transfected into 293T cells, each having different tags to allow detection of self-association. Extracts from the transfectants were then subjected to immunoprecipitation with anti-HA, followed by immunoblotting with anti-Myc, to determine if a fraction of the Myc-tagged partner was found in the precipitate (see "Materials and Methods"). When HA-tagged CFP-Rac1(WT) was immunoprecipitated, it was able to pellet either Myc-tagged YFP-Rac1(WT) or Myc-tagged YFP-Rac1(R66A) based on immunoblotting, consistent with the FRET observations (Fig. 6, B-F). On the other hand, any disruption of the prenylation site (Rac1(C189S)) or the PBR (Rac1(6Q)) was sufficient to interfere with co-immunoprecipitation (Fig. 6, B-F). This loss of association was true even if only one of the partners was lacking the critical carboxyl-terminal sequences (Fig. 6, B and F; wt + 6Q and wt + C189S) or if membrane localization was forced by adding a Lyn myristoylation site (Fig. 6, B and F; Lyn constructs). Therefore, there is concordance between the two assays for detecting interaction, since Rac1 self-association is sufficiently long lived to survive detergent extraction and immunoprecipitation. Furthermore, these results provide direct evidence that Rac1 self-association requires the PBR and COOH-terminal prenylation signal.
###end p 43
###begin p 44
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 5.</label>
###xml 9 79 9 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rac1 self-association of Rac1(WT) is independent of expression levels.</bold>
###xml 79 80 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 81 82 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 232 235 232 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ROI</italic>
###xml 526 529 526 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1/2</sup>
###xml 648 653 648 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel</italic>
###xml 692 693 692 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 716 719 716 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-H</italic>
###xml 867 870 865 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-H</italic>
###xml 9 871 9 869 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="45"><bold>Rac1 self-association of Rac1(WT) is independent of expression levels.</bold><italic>A</italic>-<italic>H</italic>, COS1 cells were cotransfected with mCFP-Rac1 and mYFP-Rac1 constructs, and Rac1 self-association was determined by FRET in two regions of interest (<italic>ROI</italic>) within each cell. Each data point represents results from a single cell, and data are plotted for 20 cells per construct (see &#8220;Materials and Methods&#8221;). Sensitized FRET determinations were then normalized to the total concentration of both derivatives, calculated as (mCFP-Rac1 &#215; mYFP-Rac1)<sup>1/2</sup>, and data were plotted as a function of the concentration of the derivatives in each of the regions of interest. Each <italic>panel</italic> shows data for the noted derivatives. <italic>I</italic>, summary of data from <italic>A-H</italic>. Data are plotted as the mean of the normalized FRET determinations &#177; S.E.; pooling data from all of the analyzed transfectants are displayed in <italic>A-H</italic>.</p>
###xml 9 871 9 869 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="45"><bold>Rac1 self-association of Rac1(WT) is independent of expression levels.</bold><italic>A</italic>-<italic>H</italic>, COS1 cells were cotransfected with mCFP-Rac1 and mYFP-Rac1 constructs, and Rac1 self-association was determined by FRET in two regions of interest (<italic>ROI</italic>) within each cell. Each data point represents results from a single cell, and data are plotted for 20 cells per construct (see &#8220;Materials and Methods&#8221;). Sensitized FRET determinations were then normalized to the total concentration of both derivatives, calculated as (mCFP-Rac1 &#215; mYFP-Rac1)<sup>1/2</sup>, and data were plotted as a function of the concentration of the derivatives in each of the regions of interest. Each <italic>panel</italic> shows data for the noted derivatives. <italic>I</italic>, summary of data from <italic>A-H</italic>. Data are plotted as the mean of the normalized FRET determinations &#177; S.E.; pooling data from all of the analyzed transfectants are displayed in <italic>A-H</italic>.</p></caption>
###xml 871 871 869 869 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0030960620005"/>
###xml 0 871 0 869 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig5"><label>FIGURE 5.</label><caption><p textid="45"><bold>Rac1 self-association of Rac1(WT) is independent of expression levels.</bold><italic>A</italic>-<italic>H</italic>, COS1 cells were cotransfected with mCFP-Rac1 and mYFP-Rac1 constructs, and Rac1 self-association was determined by FRET in two regions of interest (<italic>ROI</italic>) within each cell. Each data point represents results from a single cell, and data are plotted for 20 cells per construct (see &#8220;Materials and Methods&#8221;). Sensitized FRET determinations were then normalized to the total concentration of both derivatives, calculated as (mCFP-Rac1 &#215; mYFP-Rac1)<sup>1/2</sup>, and data were plotted as a function of the concentration of the derivatives in each of the regions of interest. Each <italic>panel</italic> shows data for the noted derivatives. <italic>I</italic>, summary of data from <italic>A-H</italic>. Data are plotted as the mean of the normalized FRET determinations &#177; S.E.; pooling data from all of the analyzed transfectants are displayed in <italic>A-H</italic>.</p></caption><graphic xlink:href="zbc0030960620005"/></fig>
FIGURE 5.Rac1 self-association of Rac1(WT) is independent of expression levels.A-H, COS1 cells were cotransfected with mCFP-Rac1 and mYFP-Rac1 constructs, and Rac1 self-association was determined by FRET in two regions of interest (ROI) within each cell. Each data point represents results from a single cell, and data are plotted for 20 cells per construct (see "Materials and Methods"). Sensitized FRET determinations were then normalized to the total concentration of both derivatives, calculated as (mCFP-Rac1 x mYFP-Rac1)1/2, and data were plotted as a function of the concentration of the derivatives in each of the regions of interest. Each panel shows data for the noted derivatives. I, summary of data from A-H. Data are plotted as the mean of the normalized FRET determinations +/- S.E.; pooling data from all of the analyzed transfectants are displayed in A-H.
###end p 44
###begin p 45
###xml 0 70 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rac1 self-association of Rac1(WT) is independent of expression levels.</bold>
###xml 70 71 70 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 72 73 72 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 223 226 223 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ROI</italic>
###xml 517 520 517 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1/2</sup>
###xml 639 644 639 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panel</italic>
###xml 683 684 683 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 707 710 707 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-H</italic>
###xml 858 861 856 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-H</italic>
Rac1 self-association of Rac1(WT) is independent of expression levels.A-H, COS1 cells were cotransfected with mCFP-Rac1 and mYFP-Rac1 constructs, and Rac1 self-association was determined by FRET in two regions of interest (ROI) within each cell. Each data point represents results from a single cell, and data are plotted for 20 cells per construct (see "Materials and Methods"). Sensitized FRET determinations were then normalized to the total concentration of both derivatives, calculated as (mCFP-Rac1 x mYFP-Rac1)1/2, and data were plotted as a function of the concentration of the derivatives in each of the regions of interest. Each panel shows data for the noted derivatives. I, summary of data from A-H. Data are plotted as the mean of the normalized FRET determinations +/- S.E.; pooling data from all of the analyzed transfectants are displayed in A-H.
###end p 45
###begin p 46
###xml 0 58 0 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Invasin Binding Results in Localized Rac1 Self-association</italic>
###xml 105 126 102 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis</italic>
###xml 221 222 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 342 363 339 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis</italic>
###xml 605 607 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 814 815 811 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 808 815 805 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7<italic>A</italic></xref>
###xml 916 922 913 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 1291 1297 1288 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7</xref>
###xml 1307 1308 1304 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1313 1314 1310 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1320 1326 1317 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 1449 1450 1446 1447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 1724 1725 1721 1722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1730 1731 1727 1728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1716 1731 1713 1728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, <italic>B</italic> and <italic>C</italic></xref>
###xml 1753 1754 1750 1751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1747 1754 1744 1751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7<italic>E</italic></xref>
###xml 1794 1795 1791 1792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 1886 1887 1883 1884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1892 1893 1889 1890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1878 1893 1875 1890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7, <italic>A</italic> and <italic>B</italic></xref>
###xml 105 126 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
###xml 342 363 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
Invasin Binding Results in Localized Rac1 Self-association-Engagement of beta1 integrin receptors by the Y. pseudotuberculosis outer membrane protein invasin triggers the recruitment of Rac1 onto the phagosomal membrane (6). To examine the degree of self-association of Rac1 in response to invasin binding, we visualized Rac1 clustered about Y. pseudotuberculosis associated with COS1 after a 30-min incubation with bacteria. To analyze self-association, cells were challenged with a bacterial strain that expressed invasin as the only adhesin and lacks the ability to translocate Rac1-inactivating Yops (33). FRET analysis showed that the mCFP-Rac1 recruited around nascent phagosomes had elevated levels of self-association in comparison with the nearby Rac1 located at regions distal from the phagosomes (Fig. 7A). Rac1 on membrane ruffles displayed similar higher efficiency of self-association (data not shown; Fig. 1). This enhanced self-association was not due to simple recruitment of mCFP-Rac1 and mYFP-Rac1 to the active sites, because the FRET levels were still elevated after the FRET signals were normalized against the concentration of mCFP-Rac1, indicating that the fraction of Rac1 undergoing self-interaction is higher at the site of bacterial adhesion than at other sites (Fig. 7, compare A and B; see arrows). In addition, the increased FRET signal was dependent on the presence of Rac1 in the fusion constructs as well as the CAAX motif. When the simple mCFP-GerGer/mYFP-GerGer pair or the Lyn-mCFP-Rac1(C189S)/Lyn-mYFP-Rac1(C189S) pair was analyzed, neither was able to generate a FRET signal at any site in the host cells even on nascent phagosomes associated with sites of bacterial adhesion (Fig. 7, B and C; quantified in Fig. 7E). This is despite the fact that the CAAX-containing constructs showed evidence of concentration about the phagosomal cups (Fig. 7, A and B). Therefore, enhanced Rac1 self-association was not a result of increased membrane density resulting from invasin engagement of integrins but was a property of the presence of an intact Rac1 protein.
###end p 46
###begin p 47
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 6.</label>
###xml 9 91 9 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Stable self-association of Rac1 derivatives shows identical profile to FRET assay.</bold>
###xml 91 92 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 505 507 505 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IP</italic>
###xml 660 662 660 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IB</italic>
###xml 683 684 683 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 757 758 757 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 869 870 869 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 884 885 884 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 957 959 957 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IP</italic>
###xml 1002 1004 1002 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IB</italic>
###xml 1040 1041 1040 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1113 1114 1113 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1119 1120 1119 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 9 1245 9 1245 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="48"><bold>Stable self-association of Rac1 derivatives shows identical profile to FRET assay.</bold><italic>A</italic>, HA (YFP derivatives) or Myc (CFP derivatives) epitope tags were introduced into each of the constructs used in the FRET assays and used in co-immunoprecipitation experiments to detect stable self-association. Displayed are maps of each of the constructs used. To measure self-association, the noted CFP and YFP derivatives were co-transfected into 293T cells, and lysates were subjected to immunoprecipitation (<italic>IP</italic>) with anti-HA IgG to precipitate YFP derivatives. Association with the noted CFP derivatives was detected after gel fractionation and Western blotting (<italic>IB</italic>) with anti-Myc IgG (<italic>B</italic>), and the total amount precipitated was determined by blotting with HA (<italic>D</italic>). As controls to determine relative efficiency of immunoprecipitation, the lysates were probed with anti-Myc (<italic>C</italic>) or anti-HA (<italic>E</italic>), loading 25% of the total fraction available for immunoprecipitation. <italic>IP</italic>, immunoprecipitate, noting antibody used. <italic>IB</italic>, immunoblot, noting antibody used. <italic>F</italic>, quantitation of the fraction of Rac1 that self-associates. Bands from <italic>B</italic> and <italic>C</italic> were subjected to densitometry scanning to determine the fraction of Myc-tagged protein that associated with HA-tagged Rac1.</p>
###xml 9 1245 9 1245 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="48"><bold>Stable self-association of Rac1 derivatives shows identical profile to FRET assay.</bold><italic>A</italic>, HA (YFP derivatives) or Myc (CFP derivatives) epitope tags were introduced into each of the constructs used in the FRET assays and used in co-immunoprecipitation experiments to detect stable self-association. Displayed are maps of each of the constructs used. To measure self-association, the noted CFP and YFP derivatives were co-transfected into 293T cells, and lysates were subjected to immunoprecipitation (<italic>IP</italic>) with anti-HA IgG to precipitate YFP derivatives. Association with the noted CFP derivatives was detected after gel fractionation and Western blotting (<italic>IB</italic>) with anti-Myc IgG (<italic>B</italic>), and the total amount precipitated was determined by blotting with HA (<italic>D</italic>). As controls to determine relative efficiency of immunoprecipitation, the lysates were probed with anti-Myc (<italic>C</italic>) or anti-HA (<italic>E</italic>), loading 25% of the total fraction available for immunoprecipitation. <italic>IP</italic>, immunoprecipitate, noting antibody used. <italic>IB</italic>, immunoblot, noting antibody used. <italic>F</italic>, quantitation of the fraction of Rac1 that self-associates. Bands from <italic>B</italic> and <italic>C</italic> were subjected to densitometry scanning to determine the fraction of Myc-tagged protein that associated with HA-tagged Rac1.</p></caption>
###xml 1245 1245 1245 1245 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0030960620006"/>
###xml 0 1245 0 1245 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig6"><label>FIGURE 6.</label><caption><p textid="48"><bold>Stable self-association of Rac1 derivatives shows identical profile to FRET assay.</bold><italic>A</italic>, HA (YFP derivatives) or Myc (CFP derivatives) epitope tags were introduced into each of the constructs used in the FRET assays and used in co-immunoprecipitation experiments to detect stable self-association. Displayed are maps of each of the constructs used. To measure self-association, the noted CFP and YFP derivatives were co-transfected into 293T cells, and lysates were subjected to immunoprecipitation (<italic>IP</italic>) with anti-HA IgG to precipitate YFP derivatives. Association with the noted CFP derivatives was detected after gel fractionation and Western blotting (<italic>IB</italic>) with anti-Myc IgG (<italic>B</italic>), and the total amount precipitated was determined by blotting with HA (<italic>D</italic>). As controls to determine relative efficiency of immunoprecipitation, the lysates were probed with anti-Myc (<italic>C</italic>) or anti-HA (<italic>E</italic>), loading 25% of the total fraction available for immunoprecipitation. <italic>IP</italic>, immunoprecipitate, noting antibody used. <italic>IB</italic>, immunoblot, noting antibody used. <italic>F</italic>, quantitation of the fraction of Rac1 that self-associates. Bands from <italic>B</italic> and <italic>C</italic> were subjected to densitometry scanning to determine the fraction of Myc-tagged protein that associated with HA-tagged Rac1.</p></caption><graphic xlink:href="zbc0030960620006"/></fig>
FIGURE 6.Stable self-association of Rac1 derivatives shows identical profile to FRET assay.A, HA (YFP derivatives) or Myc (CFP derivatives) epitope tags were introduced into each of the constructs used in the FRET assays and used in co-immunoprecipitation experiments to detect stable self-association. Displayed are maps of each of the constructs used. To measure self-association, the noted CFP and YFP derivatives were co-transfected into 293T cells, and lysates were subjected to immunoprecipitation (IP) with anti-HA IgG to precipitate YFP derivatives. Association with the noted CFP derivatives was detected after gel fractionation and Western blotting (IB) with anti-Myc IgG (B), and the total amount precipitated was determined by blotting with HA (D). As controls to determine relative efficiency of immunoprecipitation, the lysates were probed with anti-Myc (C) or anti-HA (E), loading 25% of the total fraction available for immunoprecipitation. IP, immunoprecipitate, noting antibody used. IB, immunoblot, noting antibody used. F, quantitation of the fraction of Rac1 that self-associates. Bands from B and C were subjected to densitometry scanning to determine the fraction of Myc-tagged protein that associated with HA-tagged Rac1.
###end p 47
###begin p 48
###xml 0 82 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Stable self-association of Rac1 derivatives shows identical profile to FRET assay.</bold>
###xml 82 83 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 496 498 496 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IP</italic>
###xml 651 653 651 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IB</italic>
###xml 674 675 674 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 748 749 748 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 860 861 860 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 875 876 875 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 948 950 948 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IP</italic>
###xml 993 995 993 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IB</italic>
###xml 1031 1032 1031 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1104 1105 1104 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1110 1111 1110 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
Stable self-association of Rac1 derivatives shows identical profile to FRET assay.A, HA (YFP derivatives) or Myc (CFP derivatives) epitope tags were introduced into each of the constructs used in the FRET assays and used in co-immunoprecipitation experiments to detect stable self-association. Displayed are maps of each of the constructs used. To measure self-association, the noted CFP and YFP derivatives were co-transfected into 293T cells, and lysates were subjected to immunoprecipitation (IP) with anti-HA IgG to precipitate YFP derivatives. Association with the noted CFP derivatives was detected after gel fractionation and Western blotting (IB) with anti-Myc IgG (B), and the total amount precipitated was determined by blotting with HA (D). As controls to determine relative efficiency of immunoprecipitation, the lysates were probed with anti-Myc (C) or anti-HA (E), loading 25% of the total fraction available for immunoprecipitation. IP, immunoprecipitate, noting antibody used. IB, immunoblot, noting antibody used. F, quantitation of the fraction of Rac1 that self-associates. Bands from B and C were subjected to densitometry scanning to determine the fraction of Myc-tagged protein that associated with HA-tagged Rac1.
###end p 48
###begin p 49
###xml 0 82 0 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Removal of the CAAX Motif by Yersinia YopT Protease Destroys Rac1 Self-association</italic>
###xml 116 117 116 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 599 620 599 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis</italic>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 774 775 774 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 1078 1099 1078 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis</italic>
###xml 1170 1172 1170 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 1205 1226 1205 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis</italic>
###xml 1337 1338 1337 1338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1331 1338 1331 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7<italic>D</italic></xref>
###xml 1735 1737 1735 1737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 599 620 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
###xml 1078 1099 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
###xml 1205 1226 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
Removal of the CAAX Motif by Yersinia YopT Protease Destroys Rac1 Self-association-The above data argue that the CAAX prenylation motif and the PBR collaborate to promote Rac1 self-association. One possibility for how this occurs is that membrane insertion resulting from prenylation facilitates close contact between Rac1 monomers, stimulating PBR self-association. The other possibility is that insertion in the membrane is required to maintain self-association. To determine if membrane insertion was required for maintenance of the interaction, we analyzed the consequences of translocating the Y. pseudotuberculosis YopT protein into host cells on Rac1 self-association. The YopT protease activity targets membrane-localized Rac1 (13), cleaving just upstream of the CAAX box, releasing Rac1 from the membrane. If the role of the prenyl group is limited to initiating Rac1 association, then protein released from the membrane should continue to self-associate. To test this model, transfectants expressing the mCFP-Rac1/mYFP-Rac1 pair were challenged with a YopT-expressing Y. pseudotuberculosis strain, and the amount of FRET between the Rac1 pairs was determined (22). Within 1 h of incubation with Y. pseudotuberculosis, YopT had reduced Rac1 self-association, since no FRET signal could be detected between the Rac1 pairs (Fig. 7D). Therefore, because Rac1 rapidly lost self-association after release from the membrane, localization of the protein in the membrane via the prenyl groups was required to maintain this relationship. Furthermore, the loss of self-association after release from the membrane could not be due to competition for binding by RhoGDI, because removal of the prenyl group prevents recognition by RhoGDI (32).
###end p 49
###begin p 50
###xml 0 118 0 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Loss of Self-association Is Not the Cause of Defective Signaling That Results from Alterations in the Polybasic Region</italic>
###xml 370 391 370 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis</italic>
###xml 849 870 849 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis</italic>
###xml 370 391 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
###xml 849 870 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
Loss of Self-association Is Not the Cause of Defective Signaling That Results from Alterations in the Polybasic Region-To investigate the function of the Rac1 COOH terminus in invasin-promoted uptake, a strategy was pursued in which mutated plasmid-encoded Rac1 genes were introduced into cell lines that expressed endogenous Rac1. To this end, we took advantage of the Y. pseudotuberculosis YopE RhoGAP protein. YopE is translocated into mammalian cells and subsequently inactivates endogenous Rac1, thus inhibiting the phagocytosis of the bacterium. This uptake inhibition can be overcome by the exogenous expression of a GAP-insensitive (constitutively active) Rac1 allele. A number of Rac1 PBR mutants were introduced onto the constitutively active Rac1V12 allele and were transfected into COS1 cells. Cells were challenged with YopE-expressing Y. pseudotuberculosis (strain YP17/pYopE), and the extent of bacterial uptake was quantified.
###end p 50
###begin p 51
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 7.</label>
###xml 48 56 48 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia</italic>
###xml 9 67 9 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rac1 self-association is stimulated by <italic>Yersinia</italic> infection.</bold>
###xml 137 138 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 143 144 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 176 177 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 230 231 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 316 317 316 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 320 323 320 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-C</italic>
###xml 340 341 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 398 401 398 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ext</italic>
###xml 403 411 403 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bacteria</italic>
###xml 477 481 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sens</italic>
###xml 483 487 483 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRET</italic>
###xml 492 496 492 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">norm</italic>
###xml 498 502 498 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRET</italic>
###xml 582 588 582 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 616 617 616 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 776 777 776 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 770 777 770 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>I</italic></xref>
###xml 779 794 779 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White scale bar</italic>
###xml 798 799 798 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 823 829 822 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels</italic>
###xml 9 831 9 830 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="52"><bold>Rac1 self-association is stimulated by <italic>Yersinia</italic> infection.</bold> COS1 cells were transfected with mCFP-Rac1 and mYFP-Rac1 constructs (<italic>A</italic> and <italic>D</italic>), mCFP-GerGer and mYFP-GerGer (<italic>B</italic>), or Lyn-mCFP-Rac1(C189S) and Lyn-mYFP-Rac1(C189S) (<italic>C</italic>). Transfected cells were challenged the next day with a 30-min incubation of YPIII(p<sup>-</sup>) (<italic>A-C</italic>) or YP17/pYopT (<italic>D</italic>), followed by immunostaining of extracellular bacteria (<italic>Ext</italic>. <italic>bacteria</italic>) bound onto host cells. Sensitized and normalized FRET readings (<italic>sens</italic>. <italic>FRET</italic> and <italic>norm</italic>. <italic>FRET</italic>, respectively) were determined as described (see &#8220;Materials and Methods&#8221;). The <italic>arrows</italic> denote nascent phagosomes. <italic>E</italic>, mean normalized FRET levels at nascent phagosomes were plotted comparing mCFP-Rac1/mYFP-Rac1 and mCFP-GerGer/mYFP-GerGer as described in the legend to <xref rid="fig3" ref-type="fig">Fig. 3<italic>I</italic></xref>. <italic>White scale bar</italic> in <italic>D</italic>, 5 &#956;m (applies to all <italic>panels</italic>).</p>
###xml 9 831 9 830 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="52"><bold>Rac1 self-association is stimulated by <italic>Yersinia</italic> infection.</bold> COS1 cells were transfected with mCFP-Rac1 and mYFP-Rac1 constructs (<italic>A</italic> and <italic>D</italic>), mCFP-GerGer and mYFP-GerGer (<italic>B</italic>), or Lyn-mCFP-Rac1(C189S) and Lyn-mYFP-Rac1(C189S) (<italic>C</italic>). Transfected cells were challenged the next day with a 30-min incubation of YPIII(p<sup>-</sup>) (<italic>A-C</italic>) or YP17/pYopT (<italic>D</italic>), followed by immunostaining of extracellular bacteria (<italic>Ext</italic>. <italic>bacteria</italic>) bound onto host cells. Sensitized and normalized FRET readings (<italic>sens</italic>. <italic>FRET</italic> and <italic>norm</italic>. <italic>FRET</italic>, respectively) were determined as described (see &#8220;Materials and Methods&#8221;). The <italic>arrows</italic> denote nascent phagosomes. <italic>E</italic>, mean normalized FRET levels at nascent phagosomes were plotted comparing mCFP-Rac1/mYFP-Rac1 and mCFP-GerGer/mYFP-GerGer as described in the legend to <xref rid="fig3" ref-type="fig">Fig. 3<italic>I</italic></xref>. <italic>White scale bar</italic> in <italic>D</italic>, 5 &#956;m (applies to all <italic>panels</italic>).</p></caption>
###xml 831 831 830 830 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0030960620007"/>
###xml 0 831 0 830 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig7"><label>FIGURE 7.</label><caption><p textid="52"><bold>Rac1 self-association is stimulated by <italic>Yersinia</italic> infection.</bold> COS1 cells were transfected with mCFP-Rac1 and mYFP-Rac1 constructs (<italic>A</italic> and <italic>D</italic>), mCFP-GerGer and mYFP-GerGer (<italic>B</italic>), or Lyn-mCFP-Rac1(C189S) and Lyn-mYFP-Rac1(C189S) (<italic>C</italic>). Transfected cells were challenged the next day with a 30-min incubation of YPIII(p<sup>-</sup>) (<italic>A-C</italic>) or YP17/pYopT (<italic>D</italic>), followed by immunostaining of extracellular bacteria (<italic>Ext</italic>. <italic>bacteria</italic>) bound onto host cells. Sensitized and normalized FRET readings (<italic>sens</italic>. <italic>FRET</italic> and <italic>norm</italic>. <italic>FRET</italic>, respectively) were determined as described (see &#8220;Materials and Methods&#8221;). The <italic>arrows</italic> denote nascent phagosomes. <italic>E</italic>, mean normalized FRET levels at nascent phagosomes were plotted comparing mCFP-Rac1/mYFP-Rac1 and mCFP-GerGer/mYFP-GerGer as described in the legend to <xref rid="fig3" ref-type="fig">Fig. 3<italic>I</italic></xref>. <italic>White scale bar</italic> in <italic>D</italic>, 5 &#956;m (applies to all <italic>panels</italic>).</p></caption><graphic xlink:href="zbc0030960620007"/></fig>
FIGURE 7.Rac1 self-association is stimulated by Yersinia infection. COS1 cells were transfected with mCFP-Rac1 and mYFP-Rac1 constructs (A and D), mCFP-GerGer and mYFP-GerGer (B), or Lyn-mCFP-Rac1(C189S) and Lyn-mYFP-Rac1(C189S) (C). Transfected cells were challenged the next day with a 30-min incubation of YPIII(p-) (A-C) or YP17/pYopT (D), followed by immunostaining of extracellular bacteria (Ext. bacteria) bound onto host cells. Sensitized and normalized FRET readings (sens. FRET and norm. FRET, respectively) were determined as described (see "Materials and Methods"). The arrows denote nascent phagosomes. E, mean normalized FRET levels at nascent phagosomes were plotted comparing mCFP-Rac1/mYFP-Rac1 and mCFP-GerGer/mYFP-GerGer as described in the legend to Fig. 3I. White scale bar in D, 5 mum (applies to all panels).
###end p 51
###begin p 52
###xml 39 47 39 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia</italic>
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rac1 self-association is stimulated by <italic>Yersinia</italic> infection.</bold>
###xml 128 129 128 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 134 135 134 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 167 168 167 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 221 222 221 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 307 308 307 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 311 314 311 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-C</italic>
###xml 331 332 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 389 392 389 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ext</italic>
###xml 394 402 394 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bacteria</italic>
###xml 468 472 468 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sens</italic>
###xml 474 478 474 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRET</italic>
###xml 483 487 483 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">norm</italic>
###xml 489 493 489 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRET</italic>
###xml 573 579 573 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 607 608 607 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 767 768 767 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 761 768 761 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>I</italic></xref>
###xml 770 785 770 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">White scale bar</italic>
###xml 789 790 789 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 814 820 813 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">panels</italic>
Rac1 self-association is stimulated by Yersinia infection. COS1 cells were transfected with mCFP-Rac1 and mYFP-Rac1 constructs (A and D), mCFP-GerGer and mYFP-GerGer (B), or Lyn-mCFP-Rac1(C189S) and Lyn-mYFP-Rac1(C189S) (C). Transfected cells were challenged the next day with a 30-min incubation of YPIII(p-) (A-C) or YP17/pYopT (D), followed by immunostaining of extracellular bacteria (Ext. bacteria) bound onto host cells. Sensitized and normalized FRET readings (sens. FRET and norm. FRET, respectively) were determined as described (see "Materials and Methods"). The arrows denote nascent phagosomes. E, mean normalized FRET levels at nascent phagosomes were plotted comparing mCFP-Rac1/mYFP-Rac1 and mCFP-GerGer/mYFP-GerGer as described in the legend to Fig. 3I. White scale bar in D, 5 mum (applies to all panels).
###end p 52
###begin p 53
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 8.</label>
###xml 9 68 9 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rac1 self-association is not required for promoting uptake.</bold>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">3</xref>
###xml 247 248 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">4</xref>
###xml 665 672 663 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Control</italic>
###xml 9 710 9 708 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="54"><bold>Rac1 self-association is not required for promoting uptake.</bold> The indicated plasmids expressing various Rac1V12 mutants were used to transfect COS1 cells. All constructs except mCFP-Rac1(V12) were defective in self-association (Figs. <xref rid="fig3" ref-type="fig">3</xref> and <xref rid="fig4" ref-type="fig">4</xref>), whereas only mCFP-Rac1(V12)(C189S) and mCFP-Rac1(V12)(6Q) were defective in localizing on the plasma membrane. 24 h after transfection, cells were challenged with YP17/pYopE for 30 min, fixed, and then immunostained for extracellular bacteria and internalized bacteria. Uptake efficiency of 50 CFP-positive cells from each of the three coverslips was determined and summarized as mean &#177; S.E. for each construct. <italic>Control</italic>, no plasmid included in transfection.</p>
###xml 9 710 9 708 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="54"><bold>Rac1 self-association is not required for promoting uptake.</bold> The indicated plasmids expressing various Rac1V12 mutants were used to transfect COS1 cells. All constructs except mCFP-Rac1(V12) were defective in self-association (Figs. <xref rid="fig3" ref-type="fig">3</xref> and <xref rid="fig4" ref-type="fig">4</xref>), whereas only mCFP-Rac1(V12)(C189S) and mCFP-Rac1(V12)(6Q) were defective in localizing on the plasma membrane. 24 h after transfection, cells were challenged with YP17/pYopE for 30 min, fixed, and then immunostained for extracellular bacteria and internalized bacteria. Uptake efficiency of 50 CFP-positive cells from each of the three coverslips was determined and summarized as mean &#177; S.E. for each construct. <italic>Control</italic>, no plasmid included in transfection.</p></caption>
###xml 710 710 708 708 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0030960620008"/>
###xml 0 710 0 708 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig8"><label>FIGURE 8.</label><caption><p textid="54"><bold>Rac1 self-association is not required for promoting uptake.</bold> The indicated plasmids expressing various Rac1V12 mutants were used to transfect COS1 cells. All constructs except mCFP-Rac1(V12) were defective in self-association (Figs. <xref rid="fig3" ref-type="fig">3</xref> and <xref rid="fig4" ref-type="fig">4</xref>), whereas only mCFP-Rac1(V12)(C189S) and mCFP-Rac1(V12)(6Q) were defective in localizing on the plasma membrane. 24 h after transfection, cells were challenged with YP17/pYopE for 30 min, fixed, and then immunostained for extracellular bacteria and internalized bacteria. Uptake efficiency of 50 CFP-positive cells from each of the three coverslips was determined and summarized as mean &#177; S.E. for each construct. <italic>Control</italic>, no plasmid included in transfection.</p></caption><graphic xlink:href="zbc0030960620008"/></fig>
FIGURE 8.Rac1 self-association is not required for promoting uptake. The indicated plasmids expressing various Rac1V12 mutants were used to transfect COS1 cells. All constructs except mCFP-Rac1(V12) were defective in self-association (Figs. 3 and 4), whereas only mCFP-Rac1(V12)(C189S) and mCFP-Rac1(V12)(6Q) were defective in localizing on the plasma membrane. 24 h after transfection, cells were challenged with YP17/pYopE for 30 min, fixed, and then immunostained for extracellular bacteria and internalized bacteria. Uptake efficiency of 50 CFP-positive cells from each of the three coverslips was determined and summarized as mean +/- S.E. for each construct. Control, no plasmid included in transfection.
###end p 53
###begin p 54
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rac1 self-association is not required for promoting uptake.</bold>
###xml 232 233 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">3</xref>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">4</xref>
###xml 656 663 654 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Control</italic>
Rac1 self-association is not required for promoting uptake. The indicated plasmids expressing various Rac1V12 mutants were used to transfect COS1 cells. All constructs except mCFP-Rac1(V12) were defective in self-association (Figs. 3 and 4), whereas only mCFP-Rac1(V12)(C189S) and mCFP-Rac1(V12)(6Q) were defective in localizing on the plasma membrane. 24 h after transfection, cells were challenged with YP17/pYopE for 30 min, fixed, and then immunostained for extracellular bacteria and internalized bacteria. Uptake efficiency of 50 CFP-positive cells from each of the three coverslips was determined and summarized as mean +/- S.E. for each construct. Control, no plasmid included in transfection.
###end p 54
###begin p 55
###xml 149 155 149 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 157 169 157 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mCFP-Rac1V12</italic>
###xml 336 342 336 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 344 378 344 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mCFP-Rac1V12(C189S) versus Rac1V12</italic>
###xml 380 381 380 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 503 509 501 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 511 547 509 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mCFP-Rac1V12(6Q) versus mCFP-Rac1V12</italic>
###xml 549 550 547 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 790 792 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 843 844 839 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 849 850 845 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 840 851 836 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">1 (<italic>B</italic> and <italic>G</italic>)</xref>
###xml 858 859 854 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 864 865 860 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 856 866 852 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">5(<italic>H</italic> and <italic>I</italic>)</xref>
###xml 1069 1075 1065 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 1077 1115 1073 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mCFP-Rac1V12(K186E) versus Rac1V12(6Q)</italic>
###xml 1117 1118 1113 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
As demonstrated previously, Rac1V12 restored significant bacterial uptake in the presence of YopE, allowing the effects of mutations to be compared (Fig. 8, mCFP-Rac1V12). Not surprisingly, the Rac1V12(C189S) derivative that lacks gerenylgerenylation, and therefore could not target to the membrane, was unable to bypass YopE activity (Fig. 8; mCFP-Rac1V12(C189S) versus Rac1V12; p </= 0.0004). Similarly defective was the RacV12(6Q) mutant, which also could not restore uptake in the presence of YopE (Fig. 8; mCFP-Rac1V12(6Q) versus mCFP-Rac1V12; p </= 0.004). Thus, invasin-mediated uptake required the PBR. To determine if the defect in uptake seen in these mutants was due to an absence of self-association or due to loss of effector interactions, the K186E effector binding mutation (34) that also lowers Rac1 self-association (Figs. 1 (B and G) and 5(H and I)) was analyzed. The effect of this mutation on bacterial uptake was similar to that seen with the 6Q mutation, since the two derivatives showed no statistical difference in being able to promote uptake (Fig. 8; mCFP-Rac1V12(K186E) versus Rac1V12(6Q); p = 0.47).
###end p 55
###begin p 56
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 404 405 404 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 551 557 551 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 578 584 578 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 609 610 609 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 860 861 860 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">4<italic>E</italic></xref>
###xml 863 864 863 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">5<italic>D</italic></xref>
###xml 870 871 870 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">6</xref>
###xml 905 911 905 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 1090 1096 1090 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 1113 1119 1113 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 1143 1144 1143 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1316 1317 1316 1317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1310 1317 1310 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>F</italic></xref>
Since both the 6Q and C189S mutations reduce plasma membrane localization of Rac1, we could not determine if lowered uptake was a result of lowered self-association, effector interactions, or plasma membrane localization (14). To address this issue, uptake was analyzed under conditions in which plasma membrane localization of the mutant Rac1 proteins was forced, using the constructs that have a Lyn NH2-terminal myristoylation site (24). The addition of the Lyn myristoylation site significantly suppressed the defect observed in the C189S mutant (Fig. 8; mCFP-RacV12(C189S) versus Lyn-mCFP-RacV12(C189S); p < 0.004). Therefore, the loss of uptake that results from lack of prenylation appears to be almost totally due to defective membrane localization, because the Lyn construct lacking the prenylation site showed no evidence of self-association (Figs. 4E,5D, and 6) yet still could promote uptake (Fig. 8). On the other hand, if the 6Q mutation was introduced into the Lyn construct (Lyn-Rac1V12(6Q/C189S)), then uptake was as poor as observed in the construct lacking the Lyn site (Fig. 8; Rac1V12(C189S) versus Lyn-Rac1V12(6Q/C189S); p < 0.6). The defect in uptake resulting from the 6Q mutation was unlikely to be due to poor plasma membrane localization, because the myristoylation site was intact (Fig. 3F).
###end p 56
###begin p 57
Since self-association of Rac1 does not appear to be essential for promoting invasin-mediated uptake in this system, and the 6Q mutation that replaces the PBR is defective even when plasma membrane localization is forced, the PBR must be required either for recognition by downstream effectors or RacGEF proteins. The importance of the latter could not be the cause of the defect in this assay, because Rac1V12 derivatives were used, which do not require guanine nucleotide exchange factors for activation. The importance of PBR recognition by effectors for invasin-dependent uptake is supported by results using the K186E mutant. Therefore, it appears that in this system, the PBR was required for downstream effector recognition.
###end p 57
###begin title 58
DISCUSSION
###end title 58
###begin p 59
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 698 699 698 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 824 845 824 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis</italic>
###xml 824 845 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
In this report, we used FRET technology to demonstrate that Rac1 is able to self-associate in live cells and that the highest levels of this interaction occurred at sites documented to contain the highest concentrations of actin remodeling (14, 22), such as regions of cell surface ruffling and nascent phagosome formation during bacterial uptake. These are also the regions of the cell that have the highest levels of activated Rac1 (14, 22). This result supports the model that the Rac1 PBR is an important determinant of self-association (21). Our data indicate that the PBR is not sufficient for this interaction within host cells, however, since insertion of Rac1 into the membrane via its CAAX prenylation motif was required for detectable self-association. Using an assay for the ability of Rac1 to support uptake of Y. pseudotuberculosis, we demonstrated that Rac1 self-association was not required for driving actin polymerization events that lead to internalization of the microorganism. The PBR, however, was important for efficient uptake in this system under conditions in which uptake did not require self-association of Rac1, indicating that the PBR was probably required for interaction with downstream effectors. The nature of the assay used to analyze uptake involved using constitutive active derivatives of Rac1 and did not rule out the possibility that Rac1 self-association may be important to stimulate its activation.
###end p 59
###begin p 60
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 379 380 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 373 380 373 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 648 649 648 649 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 740 741 740 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">4</xref>
###xml 746 747 746 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">5</xref>
###xml 1228 1230 1228 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 1565 1567 1565 1567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 1569 1571 1569 1571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
Rac1 self-association was originally demonstrated using gel filtration experiments, which showed that the COOH-terminal PBR was required for the formation of high molecular weight species of Rac1 that had been purified as a nonprenylated protein (21). Our observations are consistent with the importance of this region in promoting self-association within mammalian cells (Fig. 1B), but unlike this biochemical assay, we could obtain no evidence for self-association in the absence of membrane localization. In particular, the orientation of the protein relative to the membrane was extremely important, since forcing membrane localization by an NH2-terminal myristoylation tag was not sufficient to generate a Rac1:Rac1 FRET signal (Figs. 4 and 5). It may be that an important nucleation event that initiates self-interaction requires a particular orientation of the protein in the membrane. Alternatively, prenylation could target Rac1 into microdomains on the plasma membrane that are required for close association of Rac1 monomers. The second possibility has support from a pair of observations. First, active Rac1 is preferentially localized on cholesterol-rich lipid raft domains, which could stimulate self-interaction (35). Second, Rac1 preferentially self-associated at the sites of actin polymerization observed in lamellipodia and nascent phagosomes. After recruitment to these sites, there could be back-signaling to membrane-localized Rac1 that stimulates self-association. In fact, the presence of a high concentration of active Rac1 at these sites (13, 14) could act as a further important stimulus of Rac1 self-interaction, perhaps by initiating cycles of signaling from membrane-localized Rac1 to downstream effectors and back to membrane-localized Rac1.
###end p 60
###begin p 61
###xml 381 387 381 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 676 684 676 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yersinia</italic>
###xml 721 722 721 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 771 777 771 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7</xref>
###xml 1167 1169 1167 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 1336 1338 1336 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
The self-association initiated at the host cell membrane is stable in the presence of gentle detergent, but it may have a limited lifetime within a host cell once Rac1 is liberated from the membrane. The FRET data obtained in this study could be reproduced using immunoprecipitation analysis, in which epitope-tagged Rac1 variants were used to identify self-interaction complexes (Fig. 6). Only Rac1 derivatives that showed self-association by FRET analysis were positive in the immunoprecipitation assay, so the FRET analysis was a good predictor of whether multimeric Rac1 complexes could survive the detergent extraction procedure. Release of Rac1 from the membrane by the Yersinia YopT protease, which removes the CAAX prenylation signal, disrupted self-interaction (Fig. 7). This could be due to binding of soluble proteins within the cell after release or the introduction of the protein into a microenvironment within the cell that stimulates dissociation. RhoGDI is the most obvious candidate for a protein that could stimulate dissociation of Rac1 monomers; however, the proteolytic product of YopT, nonprenenylated Rac1, is not a good substrate for RhoGDI (36). Release of Rac1 from the membrane by YopT results in PBR-dependent translocation of Rac1 into the nucleus, where at least a subpopulation of the protein is active (22). Although it is not clear what downstream effectors interact with the protein in this compartment, either the biochemical environment of the nucleus or its interacting partners could interfere with self-association.
###end p 61
###begin p 62
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 514 520 514 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 1700 1702 1700 1702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 1830 1832 1830 1832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
The close correlation between results of the FRET assay and the co-immunoprecipitation of Rac1 derivatives indicated that the FRET analysis could be reproduced using traditional methods of detecting interaction. This connection was not predicted from previously published work using membrane-targeted CFP/YFP derivatives, which indicated that acylated proteins inserted into membranes associate with each other in the absence of any evidence of stable protein interactions (24). Using live cell imaging, Zacharias et al. (24) showed that the geranylgeranylated mYFP/mCFP pair generated a concentration-independent FRET signal. The FRET by proximity observed in that work, in the absence of any protein domains that promote interaction, is thought to be due to the formation of microdomains within membranes, resulting in close congregation of proteins (24). Although not investigated in that work, it is unlikely that such proximity interactions could have survived detergent extraction and allowed co-immunoprecipitation of protein pairs. Presumably, our fixation procedures prior to FRET (see "Materials and Methods") prevented fluorophores that are located on closely oriented but noninteracting proteins from generating a signal, indicating that only strong protein-protein interactions can be detected. A recent study indicates that fixation can reduce the yield of FRET in selected circumstances, particularly when both fluorophores are fused on a single polypeptide. Mathematical modeling indicates that a likely explanation for this reduction is that with some FRET pairs, fixation can limit protein flexibility and lock the fluorophores in conformations that interfere with energy transfer (38). Although such interference appears irrelevant in the case of two physically unlinked proteins that have interacting regions (38), it is possible that FRET caused by proximally localized but noninteracting proteins requires a level of flexibility of the fluorophore that is blocked by fixation.
###end p 62
###begin p 63
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 353 354 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 958 979 958 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. pseudotuberculosis</italic>
###xml 958 979 <span type="species:ncbi:633">Y. pseudotuberculosis</span>
It has been suggested that PBR-mediated self-association of Rac1 might drive optimal effector signaling, based on the observation that a PBR-defective Rac1 derivative was highly defective in activating one of its downstream effectors, the serine/threonine kinase PAK1 (21). Arguing against this hypothesis were results from another study showing that NH2-terminal myristoylation could fully restore the ability of the PBR-defective Rac1 to activate the kinase activity of PAK1 (13). From our studies, we think it likely that the restoration of PAK1 signaling was due to the myristoyl group forcing membrane localization of the Rac1 mutant rather than due to self-association. Our results support the idea that the loss of membrane targeting that results from the disruption of the PBR is a more profound consequence than loss of self-association, because membrane targeting of Rac1 in the absence of self-association appeared sufficient to promote uptake of Y. pseudotuberculosis. A membrane-targeted myristoylated Rac1V12(C189S) did not self-associate, yet this activated Rac1 mutant was able to restore bacterial uptake under conditions in which the endogenous Rac1 was inactive, as long as the PBR was intact in such constructs.
###end p 63
###begin p 64
###xml 199 200 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 202 204 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 206 208 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 210 212 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref39">39</xref>
###xml 312 313 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 622 628 618 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 764 766 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
In addition to promoting self-association and membrane targeting, the PBR is known to facilitate nuclear localization of Rac1 and binding to PIP5Kalpha as well as other downstream effectors of Rac1 (7, 31, 37, 39). Phosphatidylinositol 4,5-bisphosphate, the product of PIP5K, stimulates invasin-promoted uptake (6). Therefore, the importance of PBR could be explained by its ability to stimulate localized phosphoinositol 4,5-bisphosphate accumulation at the phagocytic cup. The fact that we could not bypass the requirement for the PBR in bacterial uptake by simply forcing localization of the protein into the membrane (Fig. 8) was very different from the result showing that PAK1 signaling was PBR-independent after localization of Rac1 in the plasma membrane (14). Therefore, stimulation of PAK1 is probably not sufficient to bypass the requirement of this sequence determinant for bacterial uptake. Consistent with this hypothesis was the finding that a less drastic change in the PBR that interferes with PIP5Kalpha binding (the Rac1(K186E) allele), was sufficient to interfere with the ability of a membrane-localized and constitutively active Rac1 variant to promote uptake.
###end p 64
###begin p 65
###xml 279 285 279 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8</xref>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 839 841 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 1342 1344 1342 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
Although the evidence presented here argue that loss of multimerization resulting from alterations in the PBR cannot explain the observed defects in invasin-mediated uptake, it should be pointed out that the Rac1 variants used to test uptake were activated forms of the protein (Fig. 8). It is possible that this approach bypasses a requirement for multimerization. At least for the integrin receptor, multimerization is important, although this does not mean that downstream signaling molecules require multimerization. Artificially dimerizing invasin greatly reduces the concentration of the protein required to promote uptake of particles (19). The evidence that downstream multimerization my play a role in regulating this event is that many GTPases are known to form oligomers, an event associated with self-stimulatory GAP activity (21). Although this latter observation argues that multimerization plays a negative role in signaling, self-inhibition of Rac1 may provide a mechanism to limit Rac1 activation that is important for successful completion of cytoskeletal activities. Such negative feedback may be critical at sites of local Rac1 activity, especially when GAP and RhoGDI activities are expected to be down-regulated. Since downstream signaling from Rac1 to other GTPases has complex consequences on invasin-mediated uptake (23), localized down-modulation of Rac1 signaling could play an important role in completing phagocytic events.
###end p 65
###begin p 66
Future critical tests of the importance of multimerization in either down-modulation of Rac1 activity or stimulating downstream signaling will require the development of straightforward systems to analyze mutants at limiting and highly defined protein concentrations. Even so, this work demonstrates that multimerization and membrane localization promoted by the PBR do not encompass the entire spectrum of events that are modulated by this small region of the protein.
###end p 66
###begin p 67
###xml 47 52 <span type="species:ncbi:69235">Molly</span>
We thank Drs. Matt Heidtman, Matthias Machner, Molly Bergman, and Vicki Auerbuch for reviewing the manuscript and Drs. Jim Bliska, Ulla Knaus, and Kit Wong for supplying plasmids.
###end p 67
###begin p 68
The abbreviations used are: FRET, fluorescence resonance energy transfer; PBR, polybasic region; CFP, cyan fluorescent protein; mCFP, monomeric CFP; YFP, yellow fluorescent protein; mYFP, monomeric YFP; WT, wild type; GAP, GTPase-activating protein; HA, hemagglutinin; PIP5K, phosphatidylinositol-4-phosphate 5-kinase.
###end p 68

